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Heat shock proteins (HSPs) are stress-inducible and evolutionarily conserved 
molecular chaperones that are involved in protein binding and translocation. As 
molecular chaperones, HSPs bind to denatured proteins, inhibit their aggregation, 
maintain their solubility, and assist in refolding. This process inhibits the formation of 
protein aggregates which can be lethal to the cell. In eukaryotic cells, the ubiquitin-
proteasome system (UPS) is responsible for the degradation of most non-native proteins. 
Furthermore, proteasome inhibition has been shown to induce hsp gene expression. 
Celastrol, a quinone methide triterpene, was shown to have an inhibitory effect on 
proteasome function in mammalian cells. The present study determined that celastrol 
induced the accumulation of ubiquitinated proteins and reduced proteasomal 
chymotrypsin-like activity in Xenopus laevis A6 kidney epithelial cells. In addition, 
incubation of A6 cells with celastrol induced the accumulation of HSP30 and HSP70 in a 
dose- and time-dependent manner with maximal levels of HSP accumulation occurring 
after 18 h of exposure. In A6 cells recovering from celastrol, the relative levels of HSP30 
and HSP70 accumulation remained elevated for 18-24 h after removal of celastrol. The 
activation of heat shock factor 1 (HSF1) DNA-binding may be involved in celastrol-
induced hsp gene expression in A6 cells, since the HSF1 inhibitor, KNK437, repressed 
the accumulation of HSP30 and HSP70. Exposure of A6 cells to simultaneous celastrol 
and mild heat shock treatment enhanced the accumulation of HSP30 and HSP70 to a 
greater extent than the sum of both stressors individually. Additionally, concurrent 
treatment of A6 cells with low concentrations of both celastrol and MG132 produced 
different patterns of HSP30 and HSP70 accumulation. While combined treatment with 
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celastrol and MG132 acted synergistically on HSP30 accumulation, relative levels of 
HSP70 were similar to those observed with MG132 alone. Immunocytochemical analysis 
of celastrol- or MG132-treated A6 cells revealed HSP30 accumulation in a punctate 
pattern primarily in the cytoplasm with some staining in the nucleus. Also, in some cells 
treated with celastrol or MG132 large HSP30 staining structures were observed in the 
cytoplasm. Lastly, exposure of A6 cells to celastrol induced rounder cell morphology, 
reduced adherence and disorganization of the actin cytoskeleton. In conclusion, this study 
has shown that celastrol inhibited proteasome activity in amphibian cultured cells and 
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1  Introduction 
1.1  Protein homeostasis and the heat shock response  
The preservation of protein homeostasis is essential to cellular survival and is 
influenced by many molecular processes including protein synthesis, folding, 
translocation, disaggregation, and degradation (Morimoto and Santoro, 1998; Balch et al., 
2008). Deficiencies in maintaining proteostasis are associated with a wide range of 
human disorders including amyotrophic lateral sclerosis (ALS), Huntington’s, 
Parkinson’s, Alzheimer’s and prion diseases (Hartl, 1996; Kakizuka, 1998; Morimoto and 
Santoro, 1998; Westerheide and Morimoto, 2005; Balch et al., 2008).  
Biochemical properties responsible for protein function and stability are disrupted 
as a result of exposure to chronic or acute stress conditions causing proteins to unfold into 
unstable conformations (Morimoto and Santoro, 1998; Morimoto, 1998; Balch et al., 
2008). These non-native proteins possess exposed hydrophobic amino acid residues and 
regions of unstructured polypeptide backbone that can interact with neighbouring side 
chains to form large non-functional aggregates (Morimoto, 1998; Hartl, 1996; Hartl and 
Hayer-Hartl, 2009). Due to molecular crowding, large aggregates within the cytosol can 
become toxic and disrupt proper cellular functioning (Morimoto and Santoro, 1998; 
Morimoto, 1998; Balch et al., 2008).  
Molecular chaperones are vital modulators of proteostasis that are abundantly 
expressed in multiple compartments of the cell. They prevent aggregation by maintaining 
misfolded proteins as soluble partially folded intermediates that are subsequently refolded 
by co-chaperones or targeted for degradation (Moriomoto, 1998; Westerheide and 
Morimoto, 2005; Morimoto, 2008). 
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In response to proteotoxic stress, cells utilize the heat shock response (HSR) to 
up-regulate molecular chaperones, proteases, and other cytoprotective agents to prevent 
and facilitate recovery from stress-induced cellular damage (Hartl, 1996; Morimoto and 
Santoro, 1998; Westerheide and Morimoto, 2005; Morimoto, 2008). The HSR is an 
evolutionarily conserved mechanism, first discovered by Ferrucio Ritossa in the salivary 
glands of Drosophila in 1962 (Jolly and Morimoto, 2000; Katschinski, 2004). Over the 
past 30 years, members of the heat shock protein (HSP) gene family have been 
characterised in most organisms ranging from archaebacteria to mammals (Parsell and 
Lindquist, 1993; Morimoto and Santoro, 1998; Jolly and Morimoto, 2000; Prahlad and 
Morimoto, 2009).  
1.2  Heat shock proteins (HSPs) 
HSPs are a family of molecular chaperones involved in the promotion of cellular 
viability in response to diverse environmental and physiological stressors such as 
elevated temperature, infection, oxidative stress, and exposure to heavy metals (Heikkila, 
2004; Westerheide and Morimoto, 2005). As molecular chaperones, HSPs protect 
denatured proteins from aggregation while maintaining their solubility to assist in their 
refolding, once normal conditions have been re-established (Morimoto,1998; Heikkila, 
2004). HSPs have been characterized into six major families based on size, including 
HSP100, HSP90, HSP70, HSP60, HSP40, and the small HSPs (Heikkila, 2004; 
Westerheide and Morimoto, 2005). They can be constitutively expressed, strictly stress 
inducible, or both inducible and constitutively regulated (Morimoto, 2008). The stress-
induced transcription of hsp genes is mediated by interactions between heat shock 
transcription factors (HSFs) and the cis-acting heat shock element (HSE). The HSE 
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consists of multiple inverted repeats of the pentamer sequence 5`-nGAAn-3` and is found 
in the 5` upstream region of most stress-inducible hsp genes (Morimoto and Santoro, 
1998; Heikkila, 2004; Westerheide and Morimoto, 2005).  
1.3  Stress induced regulation of hsp gene expression 
1.3.1  Heat shock transcription factors  
Sacchromyces cerevisiae, Caenorhabditis elegans, and Drosophila melanogaster 
express a single type of HSF that mediates induction of the HSR, while plants and 
vertebrate animals express multiple HSFs with specialized and related functions 
(Morimoto and Santoro, 1998; Voellmy, 2004; Voellmy and Boellman, 2007). In addition 
to their role in stress resistance, hsf gene expression also contributes to cell maintenance 
and developmental processes under normal physiological conditions. For example, in 
Drosophila, HSF is essential for larval development and oogenesis independent of hsp 
gene expression (Jedlicka et al., 1997). Additionally, while yeast HSF is required for 
survival and regulates genes associated with metabolism and cell wall integrity 
(Yamamoto et al., 2005; Yamamoto et al., 2009), HSF1 is a maternal factor required for 
extra-embryonic development and female fertility in mice (Xiao et al., 1999; Christians et 
al., 2000; Kallio et al., 2002). 
The expression of multiple HSFs in higher vertebrates likely serves as an additional 
mechanism to detect and respond to diverse forms of stress (Morimoto and Santoro, 
1998).  Thus far, four HSFs have been identified in vertebrates (HSF1-4). While HSF1, 
HSF2, and HSF4 are expressed in mammals,  HSF3 appears to be an avian-specific 
transcription factor (Voellmy, 2004; Voellmy and Boellman, 2007; Yamamoto et al., 
2009).  HSF1 is functionally equivalent to yeast and Drosophila HSF and is considered 
4 
 
the primary eukaryotic transcription factor responsible for the stress-induced expression 
of hsp genes (Morimoto, 1998; Heikkila, 2004).  
 Detectable levels of HSF2 activity only occur in embryonic tissues and specifically 
contribute to the developmental regulation of hsp gene expression (Rallu et al., 1997; 
Voellmy, 2004). Recent data collected using chromatin immunoprecipitation (ChIP) 
showed that both HSF1 and HSF2 are recruited to the hsp70 promoter in response to heat 
shock and hemin treatment (Ostling et al., 2007). In addition, evidence acquired using 
RT-PCR suggested that in the presence of HSF1, HSF2 contributes to the transcriptional 
regulation of multiple hsp genes including mouse hsp25, hsp40, hsp70, and hsp110 in 
response to heat shock and proteasome inhibition (Ostling et al., 2007). In avian cells, 
HSF3 is required for stress-induced hsp gene expression and the combined functional 
roles of avian HSF1 and HSF3 seem to be equivalent to mammalian HSF1 activity 
(Nakai, 1999; Voellmy, 2004). Lastly, HSF4 is expressed in a tissue-specific manner and 
has two isoforms; HSF4a and HSF4b. HSFa appears to function as a repressor of hsp 
gene expression while, HSF4b is capable of activating transcription. Whether  HSF4 is 
stress-inducible remains unclear (Tanabe, 1999; Pirkkala, 2001).  
1.3.2  HSF1 structure and regulation 
Exposure to proteotoxic stress results in the conversion of HSF1 from its inactive 
monomeric form to an active trimer with DNA binding capabilities. Following activation, 
HSF1 undergoes nuclear localization and associates with HSE to up regulate hsp gene 
expression (Morimoto and Santoro, 1998; Holmberg et al., 2002). HSF1 activity is 
regulated by various mechanisms including; intramolecular interactions between 
conserved hydrophobic domains, chaperone-mediated repression, and posttranslational 
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modifications (Morimoto and Santoro, 1998). Previous studies have found that certain 
chemicals can induce HSF1 trimerization and DNA binding activity without enhancing 
HSP accumulation. This suggests that the acquisition of HSE DNA-binding activity and 
transcriptional activation are two independently regulated steps required for HSF1 
activation (Bruce et al., 1993; Zuo et al., 1995; Voellmy, 2004).  
Through analyses of HSF1 structure and sequence conservation, several domains 
involved in the regulation of HSF1 activation have been identified including; the helix-
turn-helix DNA binding domain, an adjacent hydrophobic repeat sequence (HR-A/B) 
essential for trimerization, and a carboxy-terminal transcriptional activation domain 
(Morimoto, 1998; Voellmy, 2004) (Fig.1). An additional hydrophobic repeat sequence 
(HR-C) absent in yeast HSF and mammalian HSF4 is located adjacent to the transcription 
activation domain (Morimoto, 1998; Voellmy, 2004) (Fig. 1). Under normal conditions 
interactions between HR-A/B and HR-C contribute to the suppression of HSF1 
trimerization, while a conserved sequence located between HR-A/B and HR-C is thought 
to negatively regulate DNA-binding and transcriptional activation (Fig. 1) (Morimoto, 












Figure 1. General structure of HSF1. Schematic representation of HSF1 structural 
motifs that correspond to the helix-turn-helix DNA binding domain, hydrophobic repeat 
sequences (HR-A/B and HR-C), the carboxy terminal transcription activation domain, 








Immunodepletion experiments have shown that under non-stressful conditions,  
HSF1 trimerization and DNA binding activity is repressed through interactions with 
various HSPs and co-chaperones including HSP70, HSP90, HSP40, HIP, HOP, and P23 
(Bharadwaj et al., 1999; Voellmy, 2004). These chaperones form a multimeric complex 
with HSF monomers in which HSP90 functions as the primary inhibitor. During stress, 
this complex is disrupted as a result of increased levels of denatured protein enabling 
unbound HSF1 monomers to trimerize (Morimoto, 1998; Bharadwaj et al., 1999; 
Voellmy, 2004) (Fig. 2 & 3). HSF1 trimers subsequently relocalize to the nucleus and 
associate with HSE to facilitate hsp gene expression (Morimoto and Santoro, 1998; 
Heikkila, 2004; Voellmy, 2004; Westerheide and Morimoto, 2005). 
Once activated HSF1 is further modified post-translationally by phosphorylation, 
sumoylation, and/or acetylation at conserved amino acid residues, providing an additional 
step of regulation (Holmberg et al., 2002; Morimoto, 2008). Conserved serine residues 
are both inducible and constitutively phosphorylated. The mechanism responsible for 
HSF1 phosphorylation is unknown but in general, constitutively phosphorylated serine 
residues appear to suppress HSF1 activation under normal conditions whereas, the 
inducible phosphorylation of serine residues is associated with the promotion of HSF1 
activity in response to stress (Holmberg et al., 2002; Morimoto, 2008). Additionally, the 
ratio between activated and repressed phosphorylation sites likely varies in accordance to 
levels of HSF1 transcriptional activity (Holmberg et al., 2002; Voellmy, 2004).  
Sumoylation at conserved lysine residues also occurs in response to stress, this process 
occurs in a phosphorylation dependent manner and plays a role in regulating HSF1 DNA 











Figure 2. Chaperone mediated repression of HSF1 trimerization. The current model 
for the regulation of HSF1 activity suggests that the inactive form of HSF1 is associated 
with an HSP90 multicomplex that inhibits trimerization under normal conditions. The 
initial binding of HSP70 and HSP40 is thought to recruit HSP90 with the help of the 















Figure 3. Competitive binding of molecular chaperones to non-native proteins. An 
increase in the level of non-native proteins in response to stress, results in the 
disassembly of the HSF1-HSP90 multicomplex, causing  HSF1 monomers to trimerize 







2003; Anckar et al., 2006). Lastly, recent studies suggest that the inducible 
acetylation of HSF1 negatively regulates DNA binding activity and plays a role in the 
attenuation of the HSR (Westerheide et al., 2009). 
1.4   Small heat shock proteins  
Members of the small HSP family, which includes the stress-inducible lens 
protein α-crystallin, range in size from 12 to 43 kDa (MacRae, 2000; Van Montfort et al., 
2001; Heikkila, 2003).  Small HSPs form high molecular weight complexes up to 1 Mda 
in size that are necessary for chaperone activity in response to heat shock and other 
stressors (Heikkila, 2003; Sun and MacRae, 2005). Sequence similarities between 
members of the small HSP family are generally restricted to an 80-100 amino acid 
sequence termed the α-crystallin domain that is flanked by two poorly conserved terminal 
extensions (Sun and MacRae, 2005). The N-terminal extension of the small HSP amino 
acid sequence influences oligomer formation and chaperone activity, while stabilization 
of quaternary structure and protein solubility occurs at the C-terminal extension (Sun and 
MacRae, 2005). The secondary structure of the α-crystallin domain primarily consists of 
β-strands organized into β-sheets required for dimer formation, the basic functional units 
of small HSPs (MacRae, 2000). Small HSPs bind partially denatured proteins in an 
energy-independent manner, keeping them in a folding competent state so that they may 
be refolded by other ATP-dependent chaperones such as HSP70. These actions protect 
proteins from irreversible aggregation during various stress conditions (MacRae, 2000; 




 In vivo experiments have suggested various functions for small HSPs including 
actin polymerization, cellular differentiation, modulation of redox parameters, 
interactions with pro- and anti-apoptotic signalling factors, and the acquisition of 
thermotolerance (Arrigo, 1998; MacRae, 2000; Van Montfort et al., 2001; Paul et al., 
2002; Rane et al., 2003). As a result, the role of small HSP activity in several medical 
conditions such as multiple sclerosis, cancer, neurodegenerative disorders, and muscle 
myopathy are currently being investigated (Birnbaum and Kotilinek, 1997; Clark and 
Muchowski, 2000; Jolly and Morimoto, 2000; Westerheide and Morimoto, 2005). 
1.5 Heat shock protein 70  
The hsp70 gene family is highly conserved and is involved in regulating protein 
folding during normal and stress conditions (Katschinski, 2004). In general, eukaryotes 
possess multiple species of HSP70 capable of exhibiting both redundant and gene-
specific functional properties (Daugaard et al., 2007). The HSP70 amino acid sequence 
consists of a highly conserved N-terminal ATPase domain that is involved in the binding 
and release of non-native proteins (Katchinksi, 2004; Daugaard et al., 2007). 
Additionally,  an EEVD motif present in the C-terminal region, allows cytoplasmic 
HSP70 to interact with other HSPs and cochaperones such as HIP, HOP, and HSP40 
(Katchinksi, 2004; Daugaard et al., 2007). Binding at this motif may be responsible for 
HSP70 function and target protein specificity (Katchinksi, 2004; Daugaard et al., 2007). 
Examples of essential housekeeping functions performed by HSP70 family members 
include the translocation of proteins across cell membranes, protein folding, and the 




1.6 Xenopus laevis as a model organism 
As aquatic animals, amphibians have a high tolerance for dynamic environmental 
conditions and are a popular experimental system used to study eukaryotic stress 
response and embryonic development. They possess physiological traits common to most 
other vertebrates and data collected using amphibian systems are often applicable to 
mammals (Burggren and Warburton, 2007). The South African Clawed frog,  Xenopus 
laevis, has been utilized as a model system in cell and developmental biology for many 
decades. They are completely aquatic and utilize both cutaneous and pulmonary forms of 
respiration (Heikkila, 2003; Burggren and Warburton, 2007). Studies using X. laevis have 
provided insight into the various mechanisms of HSR regulation and the characterization 
of eukaryotic HSPs (Heikkila, 2003; Heikkila et al., 2007).  
1.6.1  X. laevis A6 kidney epithelial cell line 
 The X. laevis A6 kidney epithelial cell line is a popular system used for in vitro 
analysis of the HSR. This continuous cell line was initiated by Keen Rafferty (1968) and 
was derived from the renal uriniferous tubule of the adult male Xenopus. At confluence, 
A6 cells form an epithelial monolayer and adapt a dome-like morphology. This cell line 
is easy to maintain and has been used to study a variety of biological mechanisms 
including renal sodium transport, cell differentiation, and cellular gravitational responses 
(Tanaka et al., 2003;Verrey et al., 2003).  Induction of the HSR following exposure to 
environmental stressors such as heat shock, sodium arsenite, cadmium, hydrogen 
peroxide and herbimycin A have been well characterised in X. laevis A6 kidney epithelial 
cells (Tam and Heikkila, 1995; Briant et al., 1997; Ohan et al., 1998; Phang et al., 1999; 
Muller et. al, 2004; Gellalchew and Heikkila, 2005; Woolfson and Heikkila, 2009). 
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Additionally, recent studies have shown that the HSF1 inhibitor, KNK437, can suppress 
the HSR and HSP-mediated acquisition of thermotolerance in A6 cells (Manwell and 
Heikkila, 2007; Voyer and Heikkila, 2008). 
1.6.2  Developmentally-regulated hsp gene expression 
X. laevis is a desirable model organism for embryo development because their 
eggs are easily obtainable in large quantities, they can be fertilized in vitro, and their 
oocytes and eggs are suitable for microinjection due to their large size (1-1.2 mm in 
diameter) (Heikkila, 2003). X. laevis embryos go through cleavage, midblastula, gastrula, 
neurula, tailbud, and tadpole stages of development (Heikkila et al., 1997; Heikkila, 
2003). The midblastula transition (MBT) is an important point in development in which 
the embryonic genome becomes transcriptionally active. MBT is also associated with an 
increase in the duration of the cell cycle, loss of synchronous cell division, and a reduced 
rate of DNA synthesis (Heikkila et al., 1997; Hair et al., 1998).  Although constitutive 
levels of hsp27, hsp70, and hsp90 mRNA was detected at earlier stages of development, 
they were not heat inducible until after MBT (Heikkila et al., 1997; Heikkila, 2003). In 
contrast, hsp30 was not stress inducible until the late neurula/early tailbud stages of 
development (Heikkila et al., 1997; Heikkila, 2003; Tuttle et. al., 2007).  
1.6.3  X. laevis Heat shock protein 30  
Members of the hsp30 gene family are the most extensively investigated 
amphibian small HSPs and have been isolated in both X. laevis and the American 
bullfrog, Rana catesbeiana (Heikkila, 2003; Mulligan-Tuttle and Heikkila, 2007). 
Multiple HSP30  isoforms detected using 2-D SDS page and immunoblot analyses 
suggested a relatively large hsp30 gene family (Tam and Heikkila, 1995). In Xenopus, 
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two hsp30 gene clusters have been isolated containing hsp30 genes A to E. The first 
cluster isolated by Bienz (1984) was comprised of hsp30A and hsp30B while, the second 
cluster identified in our laboratory contained hsp30C, hsp30D and a portion of hsp30E     
(Krone et al., 1992; Tam and Heikkila, 1995; Heikkila, 2003). While  Hsp30A contains a 
21 bp insertional mutation with a stop codon in its coding region, hsp30B is a 
pseudogene. Less is known about hsp30E since only a partial gene sequence was isolated 
(Krone et al., 1992; Heikkila, 2004).  
Previous experiments done in our laboratory have characterized hsp30C and 
hsp30D gene expression. Both hsp30C and hsp30D are intronless genes that share a high 
degree of similarity and encode 24 kDa proteins containing the conserved α-crystallin 
domain found in other small HSPs (Krone et al., 1992). Hsp30C is first heat inducible at 
the late neurula/early tailbud stage of development while hsp30D is not heat inducible 
until midtailbud (Heikkila et al., 1997; Heikkila, 2003). Additionally, in vitro and in vivo 
analyses of chaperone function have found that HSP30C and HSP30D were capable of 
molecular chaperone activity by inhibiting heat-induced target protein aggregation and 
maintaining heat or chemically denatured luciferase in a folding competent state 
(Fernando and Heikkila, 2000; Fernando et al., 2002; Abdulle et al., 2002). 
 In A6 cells, HSP30 accumulation was induced by heat shock, sodium arsenite, 
herbimycin A,  hydrogen peroxide, and cadmium treatment (Briant et al., 1997; Fernando 
et al., 2003; Muller et al., 2004; Woolfson and Heikkila, 2009). Differences in the heat 
shock induced proteins recognized by the HSP30C antibody in A6 cells compared to heat 
shocked embryos suggested that Xenopus embryos and cultured cells exhibited unique 
patterns of hsp30 gene expression in response to stress (Tam and Heikkila, 1995). In 
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addition, studies in our laboratory using confocal laser scanning microscopy have found 
that in response to 33˚C and 35˚C heat shock,  A6 cells exhibit a punctate pattern of 
HSP30 accumulation that was primarily localized in the cytoplasm (Gellalchew and 
Heikkila, 2004; Manwell and Heikkila, 2007). Similar findings with respect to HSP30 
localization were observed in cadmium or sodium arsenite-treated A6 cells (Voyer and 
Heikkila, 2008; Woolfson and Heikkila, 2009).  
1.6.4 X. laevis Heat shock protein 70  
In Xenopus, several members of  the HSP70 family have been analyzed including 
the stress-inducible HSP70, constitutively expressed heat shock cognate 70 (HSC70) and 
immunoglobulin-binding protein (BiP) (Ali et al., 1997; Briant et al., 1997; Miskovic and 
Heikkila, 1999; Ali and Heikkila, 2002). HSC70 and HSP70 reside in the cytosol and 
contain functional nuclear localization signals while, BiP is confined to the lumen of the 
endoplasmic reticulum (Goldfarb et al., 2006; Heikkila et al., 2007). Recent 
investigations on the differential effects of HSC70 and HSP70 on the formation of 
epithelial sodium channels, suggested that although they are very similar, these proteins 
do not possess identical functional properties (Goldfarb et al., 2006). To date, four 
members of the stress-inducible Xenopus hsp70 genes (hsp70A, hsp70B, hsp70C, and 
hsp70D) have been isolated and sequence analysis revealed that their coding regions were 
highly conserved (Bienz, 1984). In developmental studies, hsp70 mRNA was determined 
to be heat inducible after MBT (Heikkila et al., 1997; Lang et. al, 2000). Additionally, 
whole mount in situ hybridization analysis previously carried out in our laboratory 
demonstrated that heat shock-induced hsp70 mRNA accumulation preferentially occurred 
in the lens placode, cement gland, heart, somites, spinal cord, and proctodeum (Lang et 
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al., 2000). Previous experiments suggested that the heat-induced preferential expression 
of HSP70 and HSP30 in selected tissues was due to a lowered set point temperature for 
HSF1 activation compared to other tissue types (Lang et al., 1999; Lang et al., 2000). 
This type of thermosensitivity was also reported in adult Xenopus heart tissue (Ali et al., 
1997). The treatment of  X. laevis A6 cells with various stressors including  herbimycin 
A, hydrogen peroxide, ethanol and cadmium also induced hsp70 mRNA and protein 
accumulation (Darasch et  al.,1988; Briant et al., 1997; Muller et al., 2004; Gauley and 
Heikkila, 2006; Woolfson and Heikkila, 2009). 
1.7 HSPs and their association with cancer and neurodegenerative disease 
The overexpression of cytoprotective HSPs like HSP27 and HSP70 have been 
implicated in a variety of human cancers including lung, breast and prostate cancer 
(Malusecka et al., 2001; Melendez et al., 2006; So et al., 2007). For example, the 
inhibition of  HSP70 and HSP90 by antisense RNAs inhibited growth and induced 
apoptosis in transformed cells (Whitesell, 1994; Nylandsted, 2000; Westerheide and 
Morimoto, 2005). Additionally, it has been proposed that higher levels of hsp gene 
expression likely contribute to the acquisition of chemoresistance in certain types of 
cancer (So et al., 2007). This may occur because tumor cells rely on elevated levels of 
HSPs in order to counteract cell cycle regulators normally involved in programmed cell 
death and to resist various forms of cancer treatment (Westerheide and Morimoto 2005). 
Thus, the utilization of inhibitors of the HSR  in combination with chemotherapy may 
prove to be beneficial in the treatment of various types of cancer. 
A large number of neurodegenerative disorders are associated with the expression 
of misfolded proteins that form cytotoxic aggregates (Westerheide et al., 2004; Zhang 
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and Sarge, 2007).  Examples of these disorders include Alzheimer’s, Parkinson’s, 
amyotrophic lateral sclerosis (ALS), and polyglutamine diseases such as Huntington’s 
disease and spinocerebellar ataxias (SCAs) (Fujikake et al., 2008). Therapeutic 
approaches against neuronal degeneration must therefore involve the suppression of 
unfolded proteins in order to inhibit the downstream effects of protein aggregation that 
cause neuronal dysfunction (Fujikake et al., 2008). In fact, previous studies have 
suggested that the chaperone activity provided by overexpression of HSPs can inhibit 
aggregate formation and cellular toxicity in cells expressing polyglutamine proteins 
(Zhang and Sarge, 2007). For the above reasons, there is a great amount of interest in the 
characterisation of various inducers of the HSR for therapeutic purposes. 
1.8  Protein degradation 
 Eukaryotes possess two major systems for protein degradation that are significant 
mediators of cellular homeostasis. The first to be discovered was the lysosomal 
degradation pathway. It plays a minor role in the non-specific degradation of cellular 
proteins and is primarily responsible for the hydrolysis of extracellular or membrane 
associated proteins taken up by endocytosis (Lee and Goldberg, 1998a). Protein 
breakdown within the lysosome is facilitated by multiple acidic proteases referred to as 
cathepsins. Although lysosomal degradation is an important cellular process, the ATP 
dependent ubiquitin-proteasome system (UPS), is responsible for the majority (80-90 %) 
of protein hydrolysis occurring in the cell (Lee and Goldberg, 1998a). 
1.8.1  The ubiquitin-proteasome system  
The UPS is a degradation pathway that plays an essential role in multiple 
biological processes including; development, differentiation, cell cycle progression, 
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proliferation, and apoptosis (Yang et al., 2008; Lehman, 2009). In addition to the general 
proteolysis of mutant, unfolded or damaged proteins, the UPS can also function as a 
molecular switch that rapidly blocks the activity of target proteins involved in various 
signalling pathways including nuclear factor kappa beta (NF-kβ), Notch and hypoxia 
inducible factor 1 (HIF-1) (Leung et al., 2005; Lathia et al., 2008; Rekwirowicz and 
Marzalek, 2009). As its name suggests, the UPS consists of the ubiquitin (Ub) 
conjugating system that regulates protein degradation by the multicatalytic proteasome 
(Yang et al., 2008; Lehman, 2009). 
1.8.2 Protein ubiquitination 
Ubiquitin is an evolutionarily conserved 76 amino acid protein that serves as a 
marker for proteasome degradation when it is covalently attached to lysine residues of 
target proteins. The ubiquitination of proteins destined for degradation is a multistep 
process controlled by various ubiquitin-activating enzymes (E1-E4) (Yang et al., 2008; 
Lehman, 2009). Initially, ubiquitin is activated in an ATP-dependent manner by the 
ubiquitin-activating enzyme (E1) through adenylation and formation of a thiol-ester bond 
at its C-terminal. Following activation, ubiquitin is transferred to a cysteine residue 
within one of several distinct ubiquitin-conjugating enzymes (E2). Subsequently, the 
ubiquitin bound E2 associates with an ubiquitin ligase (E3) capable of transferring 
activated ubiquitin to the lysine residue of a specific target protein. In some cases, 
additional ubiquitin monomers are added to the ubiquitinated target to form polyubiquitin 
chains that contain 4 to 7 monomers (Hershko and Ciechanover, 1998), E4 enzymes 
facilitate the formation of these polyubiquitin chains (Koegl et al., 1999). Following 
ubiquitination, ubiquitin receptor proteins act as carriers to deliver polyubiquitinated 
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proteins to the proteasome. Ubiquitin monomers are then released from the target protein 
prior to degradation and are subsequently recycled for future use (Hershko and 
Ciechanover, 1998). 
1.8.3 The Proteasome 
The proteasome (also known as the 26S proteasome) is a multicatalytic enzyme 
complex that contains a 20S catalytic core that serves as its central processing subunit 
(Groll et al., 1997; Baumeister et al., 1998). The 20S proteasome is capable of 
hydrolyzing most unfolded protein substrates and is composed of two catalytic β rings 
(with 7 subunits) surrounded by two non-catalytic α rings (with 7 subunits) that are 
stacked to form a barrel-like structure with a narrow central catalytic cavity (Groll et al., 
1997). The catalytic activity of the β ring occurs within the β1, β2, and β5 subunits that 
posses caspase-like, trypsin-like, and chymotrypsin-like proteolytic activities, 
respectively (Groll et al., 1997; Lehman, 2009).  
Proteasomal activity is modified by the regulatory 19S and 11S subcomplexes that 
bind to either end of the 20S proteasome. The 700 kDa 19S regulator contains at least 17 
different subunits and guides access to the 20S proteasome through recognition, binding, 
unfolding, and de-ubiquitination of tagged proteins (Hershko and Ciechanover, 1998; 
Nandi et al., 2006). Due to the narrow cylindrical shape of the inner 20S cavity proteins 
must be unfolded before degradation. The 19S proteasome contains 6 ATPase subunits 
that provide the energy required to unfold these protein substrates and feed them through 
the 20S core. Remaining 19S subunits contribute to 19S assembly and de-ubiquitination 
(Hershko and Ciechanover, 1998; Nandi et al., 2006). Lastly, the 11S activator stimulates 
the peptidase activity of the 20S core and regulates the proteasome-mediated production 
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of antigenic peptides that are presented to the immune system on MHC class I molecules 
(Whitby et al., 2000). The 11S subcomplex associates with one or both ends of 20S 
proteasome and can bind in the absence or presence of the 19S subcomplex. Since the 
11S proteasome is unable to recognize or degrade ubiquitinated proteins, researchers 
have suggested that it functions as an adapter between the 20S proteasome and cytosolic 
chaperones (Hershko and Ciechanover, 1998; Nandi et al., 2006; Yang et al., 2008; 
Lehman, 2009). 
1.8.4 Proteasome inhibitors 
Many low-molecular weight proteasome inhibitors have been identified, and 
peptide aldehydes such as carbobenzoxy-L-leucyl-L-leucyl-L-leucinal (MG132), are 
among the most popular. They are substrate analogues that primarily inhibit proteasomal 
chymotrypsin-like activity (Rock et al., 1994; Lee and Goldberg, 1998b). Lactacystin and 
its derivative clasto lactacystin β-lactone, have also been identified as natural inhibitors 
of the proteasome. Lactacystin binds covalently to the hydroxyl groups of β subunits in 
the 20S proteasome, subsequently inactivating chymotrypsin- and trypsin-like 
proteasomal activities (Fenteany et al., 1995; Lee and Goldberg, 1998a). While the 
effects of MG132 are reversible, lactacystin is an irreversible modifier of proteasome 
activity (Lee and Goldberg, 1998b). 
1.9  Celastrol 
  Extracts from the Celastraceae family have been used  in traditional Chinese 
medicine as anti-inflammatory agents to treat rheumatoid arthritis, bacterial infection, and 
fever, for hundreds of years (Westerheide et al., 2004). Celastrol is a quinone methide 
triterpene derived from root bark extracts of Tripterygium wilfordii Hook F., an ivy-like 
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vine belonging to the Celastraceae family of plants. Celastrol was identified in 2002 as a 
biological agent that suppressed toxic cellular properties associated with  ALS  and 
Huntington’s disease (Westerheide et al., 2004; Kim et al., 2009). For example, 
experiments employing SDS solubility analysis and fluorescence microscopy 
demonstrated that celastrol was capable of suppressing protein aggregation and toxicity in 
HeLa cells expressing polyglutamine aggregates (Zhang and Sarge, 2007). Additionally, 
treatment with celastrol was found to be neuroprotective and improved general brain 
function in rodent models for Huntington’s,  Parkinson’s, and ALS (Kiaei et al., 2005; 
Cleren et al., 2005). Additionally, in mammalian cells celastrol induced the HSR and 
activated HSF1 with kinetics similar to those observed with heat shock, such as rapid 
activation and comparable magnitudes of induction (Westerheide et al., 2004; Trott et al., 
2008). The chemical mechanism by which celastrol elicited the HSR remains unclear. 
However, data collected by Yang et al. (2006) suggested that celastrol might have an 
inhibitory effect on proteasome activity. Thus, it is possible that the accumulation of  
ubiquitinated proteins within the cell in response to proteasome inhibition may contribute 
to celastrol-mediated induction of the HSR. Recently, the induction of hsp gene 
expression in response to proteasome inhibition has been described in amphibian cells 
(Young and Heikkila, 2009). The potential advantages of using celastrol as a small 
molecule regulator of the HSR include; the rapid activation of HSF1 similar to heat 
shock, low dosage requirements, and potential cytoprotective properties against a variety 
of stressors (Westerheide et al., 2004). Additionally, since medicinal extracts containing 
celastrol have been used as a natural remedy for many years without reported instances of 
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severe adverse effects, in vivo implications for celastrol are promising (Westerheide et al., 
2004). 
 Proteasome inhibition has a great potential for use in cancer treatment and 
prevention (An et al., 1998; Orlowski et al., 1999; Drexler et al., 2000; Li et al., 2000; 
Soligo et al., 2001). Previous studies determined that celastrol is an inhibitor of 
chymotrypsin-like activity of the 20S proteasome (Yang et al., 2006). It was also 
suggested that the conjugated ketone carbons C2 and C6 of celastrol may facilitate 
celastrol-induced proteasomal inhibition by associating with β5 subunits of the 20S 
proteasome (Fig. 4) (Yang et al., 2006). Several studies have demonstrated that celastrol 
inhibits proliferation and induces apoptosis in a wide range of cancer cell lines including; 
A549 lung, MCF-7 breast, and PC-3 prostate cancer cell lines (Chang et al., 2003; Yang 
et al., 2008). Additionally, treatment of PC-3 tumor bearing mice with celastrol for 1 to 
31 days suppressed tumor growth (Yang et al., 2006), while the treatment of human lung 
adenocarcinoma H1299 cells with celastrol in combination with other chemotherapeutic 
agents inhibited tumor invasion (Sethi et al., 2007). Accumulating evidence suggests that 
the celastrol-mediated induction of apoptosis occurs through inhibition of the NF-kβ 
signalling pathway (Jin et al.,2002; Lee et al., 2006; Sethi et al., 2007), which regulates 













Figure 4. Chemical structure of celastrol. The molecular formula for celastrol is 








Thus far, the effects of celastrol have been partially characterized in yeast and 
mammalian systems. However, there is no available information on the impact of 
celastrol in amphibian cells. The primary goal of this thesis was to determine the effect of 
celastrol on proteasome activity and hsp gene expression in Xenopus laevis A6 kidney 
epithelial cells. The objectives for this study are as follows: 
 To analyze the accumulation of cellular protein conjugated to ubiquitin in 
Xenopus A6 cells treated with celastrol or MG132 
 To examine proteasomal chymotrypsin-like activity in celastrol- or MG132-
treated Xenopus A6 cells 
 To determine the effect of celastrol on the expression of hsp30 and hsp70 genes in 
Xenopus A6 cells 
 To determine whether HSF1 activation was involved in celastrol-induced 
accumulation of HSP30 and HSP70 Xenopus A6 cells 
 To examine the pattern of HSP30 and HSP70 accumulation in  Xenopus A6 cells 
simultaneously exposed to both celastrol and a mild heat shock simultaneously  
 To determine the effect of incubating Xenopus  A6 cells concurrently with 
celastrol and MG132 on HSP30 and HSP70 accumulation 
 To analyze the celastrol-induced localization of HSP30 accumulation in Xenopus 
A6 cells 




2 Materials and Methods 
2.1 Treatment and maintenance of Xenopus laevis A6 cells 
Xenopus laevis A6 kidney epithelial cells were acquired from the American Type 
Culture Collection (ATCC, Rockville, Maryland). Cells were cultured in 55 % Leibovitz 
L-15 media (Sigma; Oakville, ON) supplemented with 10 % fetal bovine serum (FBS; 
Sigma) and 1 % penicillin (100 U/mL) and streptomycin (100 μg/mL)(Sigma) and were 
grown at 22 ºC in T-75 cm
2
 flasks. Upon confluency, cells were washed with 1 mL of 
versene [0.02 % (w/v) KCl, 0.8 % (w/v) NaCl, 0.02 % (w/v) KH2PO4, 0.115 % (w/v) 
Na2HPO4, 0.02 % (w/v) sodium ethylenediaminetetraacetic acid (Na2 EDTA)], followed 
by a 1 min incubation with 2 mL of fresh versene. Then 1 mL of 1X trypsin (Sigma) 
diluted in 100 % Hank’s balanced salt solution (HBSS; Sigma) was added until cells 
began to detach from the flask. Ten mL of fresh L-15 media was then added to the 
detached cells. The cell suspension was then divided evenly into additional flasks. Cell 
treatments were performed 2 days after cell splitting to allow the cells to reach 90-100 % 
confluence. 
Celastrol ( ≥ 98  % purity) (Cayman chemical, Ann Arbor, MI) was dissolved in 
dimethylsulphoxide (DMSO; Sigma) to make a stock solution of 10 mg/mL. The stock 
was then diluted further to make a 1 mg/mL working solution. This working stock was 
used to prepare 1, 2.5, 5, or 7.5 µM concentrations of celastrol used for subsequent 
experiments. MG132 (Sigma) and KNK437 (N-formyl-3, 4-methylenedioxy-
benzylidene-γ-butyrolactam; Calbiochem, Gibbstown, New Jersey) were also dissolved 
in DMSO to prepare 5 mg/mL stock solutions. Experiments with MG132 used 5, 10, or 
30 µM concentrations while all treatments with KNK437 used 100 µM concentrations. 
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For A6 cell treatments, appropriate volumes of each chemical were added to fresh L-15 
media followed by gentle shaking to ensure even distribution prior to adding each 
treatment to tissue culture flasks containing A6 cells. Treatments with 100 µM KNK437 
were performed 6 h prior to treatment with 2.5 µM celastrol. Heat shock treatments at   
33 ˚C were for 2 h, followed by a 2 h recovery period at 22 ˚C for protein isolation and 
without a recovery period for the isolation of RNA. Combined treatments with celastrol 
and mild 30 ˚C heat shock did not include a recovery period. Immediately following 
treatment, A6 cells were harvested by washing in 2 mL of 65 % HBSS, and were then 
removed with a cell scraper and suspended in 1 mL of 100 % HBSS. The cells were 
centrifuged at 14,000 rpm for 1 min and stored at -80 ˚C until protein or RNA isolation.  
2.2  Detection of chymotrypsin-like activity in A6 cells 
Chymotrypsin-like activity was detected from cultured A6 cells using the 
Promega  Proteasome-Glo cell based luminescent assay kit (Promega Corp., Madison, 
WI) according to the manufacturer’s recommendations as outlined below. The 
Proteasome-Glo Cell-Based Reagents each contain a specific luminogenic proteasome 
substrate (Suc-LLVY-Glo substrate for chymotrypsin-like activity) in a buffer optimized 
for cell permeabilization, proteasome activity and luciferase activity. The proteasome 
cleavage generates an aminoluciferin substrate that is consumed by luciferase to produce 
a luminescent signal at a rate proportional to proteasome activity (Promega Corp., 2009).  
After thawing the Proteasome-Glo cell based buffer, both the buffer and lyophilized 
Luciferin detection reagent were equilibrated to room temperature in the dark before use. 
It should be noted that the Suc-LLVY-Glo substrate was also thawed and equilibrated to 
room temperature in the dark. Once at room temperature the lyophilized Luciferin 
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detection buffer was reconstituted in Proteasome-Glo cell based buffer in an amber bottle 
provided by the manufacturer. Then 50 µL of the Suc-LLVY-Glo substrate was vortexed 
to remove any precipitate that may have formed. The substrate was then added to the 
amber bottle containing lyophilized Luciferin detection reagent reconstituted in 
Proteasome-Glo cell based buffer. To remove any free aminoluciferin and reduce 
background luminescence, the contents of the bottle (prepared proteasome-glo cell based 
reagent) were then mixed gently and stored at room temperature in the dark for 30 min 
before use. 
A6 cells were cultured in L-15 media supplemented with 10 % FBS and 1 % 
penicillin and streptomycin (as described in section 2.1). Following chemical treatment, 
cells were washed with 2 mL of versene and then with 1 mL of 1X trypsin until the cells 
began to detach from the flask. Nine mL of fresh L-15 media was then added to the flask. 
The media was pipetted up and down to rinse the flask surface and allow for even 
distribution. The cell suspension was then removed from the flask and placed into a       
15 mL Falcon tube. Cells were pelleted at 4 ˚C by gentle centrifugation at 4,000 rpm for  
5 min. Following centrifugation excess media was removed and pellets were washed in 5 
mL of fresh L-15 media and then centrifuged again at 4,000 rpm for 5 min at 4 ˚C. A6 
cells were then resuspended in 5 mL of fresh L-15 media. For each sample, the total 
number of cells per mL was determined using a Bright-Line haemocytometer (Hausser 
Scientific, Horsham, PA). Approximately 15,000 were suspended in 100 µL of L-15 
media for the chymotrypsin-like assay. 
For the chymotrypsin-like activity assay, 100 µL of each sample were added to 
the wells of a white-walled 96-well plate. Then 100 µL of Proteasome-Glo cell-based 
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reagent (prepared previously) was added to each sample. The plate was then covered with 
foil and samples were mixed gently on a rocking platform for 2 min. The samples were 
then incubated at room temperature for 45 min in the dark, prior to measuring 
chymotrypsin-like activity. The luminescence of each sample was measured using the 
Victor
3
 luminometer (PerkinElmer Inc., Waltham, MA). Values were then compared to a 
blank control (Proteasome-Glo cell-based reagent + L-15 media) and a no-treatment 
control (Proteasome-Glo cell-based reagent + L-15 containing DMSO).  
2.3 Antisense riboprobe production and northern blot hybridization analysis 
2.3.1 Hsp30C template construction  
The open reading frame of the hsp30C gene was previously inserted into the 
pRSET expression vector (Invitrogen, Carlsbad, CA) by Pasan Fernando (Fernando and 
Heikkila, 2000). Plasmids containing the hsp30C insert were transformed into 
Escherichia coli DH5α cells. Individual colonies were inoculated in 5 mL of LB broth [1 
% (w/v) tryptone-peptone, 0.5 % (w/v) yeast extract, 1 % (w/v) NaCl, pH 7.5] containing 
100 μg/mL ampicillin (Bioshop, Burlington, ON) and grown overnight in at 37 ˚C for 14-
16 h.  
2.3.2 Hsp70 template construction 
The coding region of hsp70 genomic DNA was previously isolated (Lang et al., 
2000) and inserted into the plasmid pSP72 (Promega, Napean, ON). Plasmids containing 
the hsp70 insert were also inoculated in 5 mL of LB broth containing 100 μg/mL 
ampicillin and grown overnight in 5 mL of LB broth containing 100 μg/mL ampicillin at 




2.3.3 Isolation of plasmid DNA 
After overnight incubation, bacterial cells were centrifuged (Eppendorf Centrifuge 
5810R, Brinkmann Instruments Ltd., Mississauga, ON) at 5,000 rpm for 5 min at 4 ˚C. 
Plasmid DNA was then isolated by resuspending the pelleted cells in 200 μL of  ice-cold 
alkaline lyisis solution #1[ 50 mM glucose, 25 mM Tris (pH 8.0) and 1 mM EDTA (pH 
8.0)] and then transferring the mixture into a microcentrifuge tube. The cells were then 
lysed by mixing them gently with 200 μL of  alkaline lysis solution #2 [0.2 M NaOH and 
1  % (w/v) SDS (sodium dodecyl sulfate)]. The microcentrifuge tubes were kept on ice 
for the remainder of the experiment. After adding 200 µL of ice-cold alkaline solution #3 
[ 3 M potassium acetate and 5 M glacial acetic acid] the tubes were mixed gently and 
placed on ice for 5 min. Next, the samples were centrifuged at 14,000 rpm for 5 min at    
4 ˚C, the supernatant was then transferred to fresh microcentrifuge tubes. This was 
followed by a 2 h RNase A treatment (10 μg/mL; BioShop, Burlington, ON) at 37 ˚C to 
eliminate RNA from the samples.  
After a 2 h  incubation, 600 μL of phenol:chloroform (1:1) was added and the 
samples were vortexed. The samples were then centrifuged at 14,000 rpm for 3 min at     
4 ˚C and the upper aqueous layer was transferred to new microcentrifuge tubes. The 
phenol/chloroform step was repeated. Next, a 600 μL solution of isoamyl 
alcohol:chloroform (1:24) was prepared and added to the microcentrifuge tubes which 
were then vortexed and centrifuged at 14,000 rpm for 3 min at 4 ˚C. Again the upper 
aqueous layer was transferred to fresh microcentrifuge tubes. To precipitate the nucleic 
acids, 600 μL of isopropanol was added to each microcentrifuge tube. The samples were 
then vortexed and incubated at room temperature for 2 min. Followed by centrifugation at 
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14,000 rpm for 5 min at room temperature. The supernatant was removed and 500 μL of 
70  % ethanol was added to wash the pellets. The samples were then centrifuged at 
14,000 rpm for 2 min at 4 ˚C. Then the ethanol was removed and the previous step was 
repeated. The pellets were allowed to air dry and were then resuspended in 50 μL distilled 
water and stored at -20 ˚C. 
2.3.4 In vitro transcription 
The plasmid containing the hsp30C  or hsp70 insert as mentioned above was 
linearized using the PvuII or MluNI restriction enzymes, respectively (Roche, Laval, 
Quebec). The linearized plasmid was then electrophoresed on a 1  % (w/v) agarose gel in 
1X modified tris-acetate EDTA buffer (TAE)( Millipore corp., Bedford, MA). The DNA 
band corresponding to the hsp30C or hsp70  insert was visualized using a UV lamp. The 
DNA band was then cut out using a razor blade. Plasmid DNA was extracted from the gel 
using the Montage DNA gel Extraction Kit (Millipore). The gel slice containing the 
plasmid DNA was placed into a gel nebulizer containing a microporous membrane filter 
(Millipore). The nebulizer tube was then centrifuged at 5,000 rcf for 10 min at 4 ˚C. The 
filter was then removed and the DNA was precipitated by adding 100  % ice-cold ethanol 
(2X volume) and 3 M sodium acetate (pH 5.2, 1/10 volume). The tube was then placed at 
-80 ˚C for 30 min and then centrifuged at 14,000 rpm for 10 min at 4 ˚C. The supernatant 
was discarded and the pellet was washed in 1 mL of 70  % ice-cold ethanol and 
centrifuged at 14,000 rpm for 10 min at 4 ˚C. The ethanol was removed and the previous 
step was repeated. The pellet was then air dried and resuspended in 20 μL of sterile water 
and kept at -20 ˚C.  
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In vitro transcription was used to generate digoxygenin (DIG)-labelled 
riboprobes. Each in vitro transcription reaction contained 4 μL of linearized DNA 
template, 4 μL of rNTP mix [2.5 mM rGTP, 2.5 mM rATP, 2.5 mM rCTP, 1.625 mM 
rUTP (Promega, Nepean, ON), 0.875 mM DIG-11-UTP (Roche), 1.5 μL 
diethylpyrocarbonate (DEPC, Sigma)-treated water, 4 μL of 100 mM (Promega), 4 μL of 
5X transcription buffer (Fermentas, Burlington, ON), 0.5 μl RNase inhibitor (Fermentas) 
and 40 IU of SP6 RNA polymerase (Roche)]. The in vitro transcription reaction was 
performed for 1 h at 37 ˚C. To remove any remaining DNA template, 2 μL of RNase-free 
DNase 1 (Roche) was added for 10 min at 37 ˚C. In vitro transcripts were then 
precipitated with the addition of 10 μL of 3 M sodium acetate (pH 5.2), 80 μL of TES [10 
mM Tris-HCl (pH 7.4), 5 mM EDTA (pH 8.0), 1  % (w/v) SDS] and 220 μL of ice-cold 
100  % filtered ethanol. The reaction was incubated at -80 ˚C for 30 min and then 
centrifuged at 14,000 rpm for 15 min at 4 ˚C. The supernatant was removed and the pellet 
was air dried and resuspended in 21 μL of DEPC-treated water. Two μL of the sample 
was electrophoresed to verify the presence of the in vitro transcript. The remaining 19 μL 
was stored at -80 ˚C until northern blot hybridization analysis. 
2.3.5 RNA isolation 
RNA was isolated from pelleted A6 cells using the Qiagen RNeasy Mini Kit 
(Qiagen; Mississauga, ON) according to the manufacturer’s protocol outlined in the 
RNeasy Mini Handbook (2009). Isolated RNA was suspended in 30-40 µL of  DEPC-
treated water and quantified using the NanoDrop ND-1000 (NanoDrop, Waltham, MA) 
spectrophotometer. Prior to northern blot analysis, RNA integrity was analysed by 
electrophoresing 2 μg of each RNA sample on a 1.2 % formaldehyde agarose gel [1.2 % 
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(w/v) agarose, 10 % (v/v) 10X MOPS, 16 % (v/v) formaldehyde]. Before the samples 
were electrophoresed, they were dissolved in 10 µL of loading buffer [1 μL 10X MOPS, 
1.6 μL formaldehyde, 2 μL RNA loading dye (0.2 % bromophenol blue, 1 mM EDTA 
(pH 8.0), 50 % (v/v) glycerol), 5 μL formamide, 0.5 μg/mL ethidium bromide] and then 
heat denatured in a 68 ˚C water bath and immediately cooled on ice for 5 min. The 
samples were then electrophoresed at 90-100 V for approximately 1 h. 
2.4 Northern blot hybridization analysis 
Ten μg of RNA was electrophoresed for 3 h at 65 V on a 1.2 % formaldehyde 
agarose gel as described above with the exception that ethidium bromide was not added 
to the loading buffer. Following electrophoresis the gel was soaked in 0.05 NaOH for    
20 min to denature RNA. Next, the gel was rinsed in DEPC-treated water and soaked 
twice for 20 min each in fresh 20X SSC buffer [3 M sodium chloride, 300 mM sodium 
citrate]. The RNA was then transferred overnight to a positively charged nylon membrane 
(Roche) by capillary action. A piece of 3MM Whatman filter paper, which served as a 
wick, was pre-soaked in 20X SSC and placed on a plexiglass support over a Pyrex dish 
containing approximately 500 mL of 20X SSC. The inverted gel was placed onto the 
wick, followed by a piece of nylon membrane slightly larger in size than the gel. This 
was then covered by two pieces of 3MM Whatman filter paper cut to the size of the gel. 
Paper towels (same size as gel) were then stacked about 6-7 cm high on top of the 
blotting paper. A plexiglass support and a weight of approximately 250 g were placed on 
top of the apparatus to aid transfer. After overnight transfer the  RNA was UV-
crosslinked to the membrane using a UVC-515 Ultraviolet Multilinker at 12,000 
MicroJ/CM
2
. The membrane was then soaked in 10 % (v/v) glacial acetic acid for 5 min. 
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The quality of the transfer was checked using 1X reversible blot stain (Sigma). The 
membrane was stained for approximately 10 min and then rinsed with DEPC-treated 
water. The stained membrane was then scanned using a Hewlett Packard ScanJet 3300C. 
Next, the membrane was  incubated in 50 mL of pre-heated prehybridization buffer [50 % 
(v/v) formamide, 5X SSC, 0.02 % (w/v) SDS, 0.01 % (w/v) N-lauryl sarcosine, 2 % (w/v) 
blocking reagent (Roche)] in a hybridization bag at 68 ˚C for 4 h in a pre-heated 
hybridization oven.  
After 4 h, the prehybridization buffer was replaced with hybridization buffer 
(same components as prehybridization buffer) containing 20 μL of either hsp30 or hsp70 
DIG-labelled antisense riboprobe. The membrane was then returned to the hybridization 
oven for overnight incubation at 68 ˚C.  
Next, the membrane was washed to remove any unbound probe. First it was 
washed twice in 2X SSC at room temperature for 5 min, then once each in 0.5X SSC and 
0.1X SSC, both at 68 ˚C for 15 min. All three SSC washing solutions contained 0.1 % 
(w/v) SDS. The blot was then equilibrated for 1 min at room temperature in washing 
buffer [100 mM maleic acid buffer, 0.3 % (v/v) Tween-20] and blocked using blocking 
solution [2 % (w/v) blocking reagent (Roche), 10 % (v/v) maleic acid buffer] for 1 h at 
room temperature. The blot was then incubated in blocking solution containing 1:8000 
alkaline phosphatase conjugated anti-DIG-Fab fragments (Roche) for 30 min. The 
membrane was then washed twice in washing buffer for 10 min each and then 
equilibrated in detection buffer [0.1 M Tris-HCl (pH 9.5), 0.1 M NaCl] for 2 min prior to 
detection using CDP-star (Roche), a chemiluminescent reagent, which was applied to the 
membrane and allowed to develop in a hybridization bag for 10 min in the dark. The 
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membrane was then visualized on a DNR Chemiluminescent Imager (DNR Bioimaging 
Systems, Kirkland, QU) for up to 12 min depending on the strength of the signal. 
2.5 Western blot analysis 
2.5.1 Protein isolation from A6 cells 
 Pelleted A6 cells were thawed on ice prior to the addition of 500 µL of lysis 
buffer containing 1 % SDS, 1X complete protease inhibitor cocktail (Roche) and 
homogenization buffer [200 mM sucrose, 2 mM EGTA, 1 mM EDTA, 40 mM NaCl,    
30 mM HEPES]. It should be noted that the lysis buffer used for samples in preparation 
for immunoblotting with a mouse anti-ubiquitin antibody contained 10 mM N-
ethylmaleimide (Sigma) to inhibit ubiquitin conjugating enzymes. After adding lysis 
buffer the cells were subjected to sonication (output 4.5, 60 % duty cycle) for 15-20 
bursts using a Fisher Scientific Sonic Dismembrator 100 (Fisher Scientific). The 
homogenate was then centrifuged at 14,000 rpm for 1 h at 4 ˚C. The supernatant was then 
transferred to a new microcentrifuge tube and stored at -20 ˚C until use. 
2.5.2 Protein quantification 
Protein was quantified using a bicinchoninic acid (BCA) Protein Assay Kit 
(Pierce, Rockford, Illinois). A bovine serum albumin (BSA; Bioshop) protein standard 
was created by diluting BSA in distilled water at concentrations ranging from                   
0 to 2 mg/mL. Protein samples were diluted to a concentration of 1:2 in milliQ water. Ten 
μL of BSA standards and protein samples were transferred in triplicate into a 96 well 
plate. Then 80 μL of BCA reagent A and B (Pierce) at a ratio 50:1 was added to the BSA 
and protein samples. The plate was tapped lightly on the side to mix samples, covered 
with foil and then incubated at 37 ˚C for 30 min. The plate was then read at 562 nm using 
39 
 
a Versamax microplate reader (Molecular Devices, Sunnyvale, CA). A standard curve 
was created in Microsoft Excel using the BSA protein standards which was used to 
determine the concentration of each protein sample. 
2.5.3 Western blot analysis 
Immunoblot analysis was performed using  20 or 60 μg of protein (depending on 
the primary antibody used) and sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE).  For SDS-PAGE, gels were electrophoresed on a BioRad 
TETRA cell electrophoresis system (BioRad; Mississauga, ON). Separating gels          
[10-12 % (v/v) acrylamide, 0.32 % (v/v) n’n’-bis methylene acrylamide, 0.375 M Tris 
(pH 8.8), 1 % (w/v) SDS, 0.2 % (w/v) ammonium persulfate (APS), 0.14 % (v/v) 
tetramethylethylenediamine (TEMED)] were prepared, poured and allowed to polymerize 
for 30 min with 100 % ethanol layered on top. Next, ethanol was poured off and the 
stacking gel [4 % (v/v) acrylamide, 0.11 % (v/v) n’n’-bis methylene acrylamide, 0.125 M 
Tris (pH 6.8), 1 % (w/v) SDS, 0.4 % (w/v) APS, 0.21  % (v/v) TEMED] was prepared, 
poured and allowed to polymerize for 30 min. Protein samples were then aliquoted and 
added to 1X loading buffer [0.0625M Tris (pH 6.8), 10 % (v/v) glycerol, 2 % (w/v) SDS, 
5 % (v/v) β-mercaptoethanol, 0.0125 % (w/v) bromophenol blue]. Samples were then 
heat denatured in a boiling water bath for 10 min, immediately cooled on ice for 5 min 
and pulse-centrifuged (6 sec at 9 rpm) prior to loading. Gels were electrophoresed with 
1X running buffer [25mM Tris, 0.2M glycine, 1 mM SDS] at 90 V until samples reached 
the separating gel, at which time the voltage was turned up to 160-170 V until the dye 
front reached the bottom of the gel.  
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Pure nitrocellulose transfer blot membranes (BioRad) and filter paper (BioRad) 
were cut to 5.5 cm x 8.5 cm, and membranes were incubated for 30 min in transfer buffer 
[25 mM Tris, 192 mM glycine, 20 % (v/v) methanol]. After electrophoresis, the stacking 
gel was cut away and the remainder of the gel was soaked in transfer buffer for 15 min. 
Protein was transferred to the nitrocellulose membrane with a Trans-Blot Semi-Dry 
Transfer Cell (BioRad) at 20 volts for 25 min. Blots were then stained with Ponceau-S 
stain [0.19 % (w/v) Ponceau-S, 5 % (v/v) acetic acid] for 12 min to determine the success 
of the transfer and equal loading. The membrane was then rinsed with MilliQ water and 
scanned with a Hewlett Packard ScanJet 3300C. The membrane was incubated in 5 % 
blocking solution [20 mM Tris (pH 7.5), 0.1 % Tween 20 (Sigma), 300 mM NaCl, 5 % 
(w/v) Nestle® Carnation skim milk powder] for 1 h to prevent nonspecific binding. The 
membrane was then incubated for 1 h in blocking solution containing the primary 
polyclonal antibody. The antibodies used were either mouse anti-ubiquitin (Zymed, San 
Francisco, CA), rabbit anti-HSP30 (Fernando and Heikkila, 2000), anti-HSP70 (Gauley 
and Heikkila) or anti-actin (Sigma) antibodies at dilutions of 1:150; 1:1000, 1:250 and 
1:200, respectively. 
Excess unbound antibody was removed by rinsing the membrane with 1X Tris-
buffered saline with Tween 20 (TBS-T) [20 mM Tris, 300 mM NaCl, (pH 7.5), 0.1 % 
Tween 20 (Sigma)]. The membrane was washed with fresh TBS-T for 15 min, followed 
by two 10 min washes with fresh TBS-T. The membrane was then incubated for 1 h with 
blocking solution containing the secondary antibody conjugate, AP-conjugated goat-anti-
rabbit (BioRad) at a 1:3000 dilution or AP-conjugated goat-anti-mouse (BioRad) at a 
1:1000 dilution. The membrane was then rinsed with TBS-T and then washed with fresh 
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TBS-T for 15 min, followed by two 5 min washes with fresh TBS-T. The membrane was 
incubated in alkaline phosphatase detection buffer [alkaline phosphatase buffer (100 mM 
Tris base, 100 mM NaCl, 50 mM MgCl2 (pH 9.5)), 0.3 % 4-nitro blue tetrazolium (NBT; 
Roche), 0.17 % 5-bromo-4-chloro-3-indolyl phosphate, toluidine salt (BCIP; Roche)] 
until the bands were visible. Images were scanned using a Hewlett Packard ScanJet 
3300C. 
2.5.4 Densitometric statistical analysis 
Densitometry was performed using Image J (1.38) software on individual blots. 
Experiments were repeated in triplicate, and the average densitometric values were 
expressed as a percentage of the maximum hybridization band or as a percent inhibition 
for KNK437 experiments. The data were graphed with standard error, represented as 
vertical error bars. The level of  significance of the differences between the samples was 
calculated using Microsoft Excel, by one-way analysis of variance (ANOVA) with a 
Tukey’s post-test. With the exception of KNK437 experiments in which two-tailed paired 
t-tests were performed to analyze the differences between samples. Confidence levels 
used were 95 % (p < 0.05). 
2.6 Immunocytochemistry and laser scanning confocal microscopy 
A6 cells were prepared for imaging by laser scanning confocal microscopy 
(LSCM) on base-washed glass coverslips in Petri dishes. Coverslips were placed in small 
Coplin jars to ensure full contact with the base solution [49.5 % (v/v) ethanol, 0.22 M 
NaOH] for 30 min with periodic shaking at room temperature. The coverslips were then 
rinsed under running distilled water for 3 h and dried on 3MM Whatman paper. Finally, 
the coverslips were stored in Petri plates sealed with parafilm and flamed in the laminar 
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flow hood prior to use. To prepare A6 cells for an experiment, coverslips were placed in 
new sterile Petri dishes and the cell suspension was added to the dish.  
The cells were then allowed to attach to the coverslips for 24 h at 22 ˚C. For 
chemical treatments, A6 cells were treated directly in the Petri dishes at 22 ˚C. In heat 
shock experiments, the Petri dishes were wrapped with parafilm, sealed in a plastic bag 
and then placed in a heated water bath.  After treatment, the L-15 media was removed 
and the cells were washed twice in phosphate-buffered saline [PBS; 1.37 M NaCl,         
67 mM Na2HPO4, 26  mM KCl, 14.7 mM H2PO4, 1 mM CaCl2, 0.5 mM MgCl2, pH 7.4] 
and the coverslips were transferred to new small Petri dishes. The cells were fixed with 
3.7 % (w/v) paraformaldehyde (pH 7.4 in PBS) for 10-15 min and then washed 3 times in 
PBS for 5 min. It should be noted that for treatments with celastrol washes were 
performed with minimal shaking to reduce impact on cell adherence. Next, the cells were 
permeabilized using 0.3 % Triton X-100 (Sigma) in PBS for 10 min and then washed 3 
times in PBS for 5 min. Finally, the cells were blocked with 3.7 % (w/v) bovine serum 
albumin fraction V (BSA fraction V; Sigma) in PBS for 1 h or overnight at 4 ˚C. The 
BSA fraction V was filter-sterilized using a 0.45 μm filter to remove debris that might 
negatively affect imaging. Cells were then incubated in primary antibody (rabbit anti- 
HSP30C at 1:500 in blocking solution) for 1 h. After three 5 min washes in PBS, the cells 
were indirectly labelled by incubation in a fluorescent-conjugated secondary antibody 
(goat-anti rabbit Alexa Fluor 488 (Molecular Probes, Eugene, OR) at 1:2,000 in blocking 
solution) for 30 min, in the dark, to avoid photo-bleaching of the fluorescent signal.  
Cells were then probed for actin with rhodamine-tetramethylrhodamine-5-
isothiocyanate phalloidin (TRITC; Molecular Probes) at 1:60 in PBS for 15 min, in the 
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dark. The cells were then washed three times for 5 min in PBS. The coverslips were 
mounted (cell side down) in one drop of VectaShield containing 4,6-diamidino-2-
phenylindole (DAPI; Vector Laboratories Inc, Burlingame, CA) on a glass slide and 
sealed with clear nail polish. Once dried, the slides were visualized with a Zeiss Axiovert 
200 microscope and LSM 510 META software (Carl Zeiss Canada Ltd., Mississauga, 
ON). The 63X oil immersion objective was utilized along with the 405 nm (for DAPI), 
488 nm (for Alexa-488) and 533 nm (for TRITC) scanning lasers. Between uses, the 




3 Results  
3.1 Analysis of heat shock induced hsp30 gene expression and HSP30 accumulation 
in Xenopus cultured cells 
A number of studies conducted in our laboratory using X. laevis A6 cells have 
shown that both hsp30 mRNA and HSP30 accumulate in response to elevated 
temperatures (Ohan et al., 1998; Phang et al., 1999; Fernando and Heikkila, 2000; 
Gellalchew and Heikkila, 2004; Young et al., 2009). Examples of northern blot 
hybridization and immunoblot analyses demonstrating heat shock-induced hsp30 gene 
expression are shown in Figure 5. In contrast to control cells, detectable levels of hsp30 
mRNA were present in cells subjected to heat shock at 33 ˚C or 35 ˚C for 2 h (Fig. 5A). 
The relative levels of hsp30 mRNA were greater in cells incubated at 35 ˚C than those 
heat shocked at 33 ˚C. Similar findings were observed with the effect of heat shock on 
HSP30 accumulation in A6 cells. HSP30 levels were detected in cells heat shocked at 33 
˚C and were relatively greater at 35˚C (Fig. 5B). It should be noted that the anti-HSP30 
antibody utilized in this study, which was prepared against the entire coding sequence of 
HSP30C, detected multiple members of the HSP30 family in immunoblot analysis 
(Fernando and Heikkila, 2000). 
The present study also examined heat shock-induced localization of HSP30 using 
immunocytochemistry and LSCM (Fig. 6). While there was no detectable HSP30 in 
control cells maintained at 22 ˚C, A6 cells heat shocked at 33 ˚C displayed a punctate 
pattern of HSP30 accumulation primarily in the cytoplasm. These results are in 






Figure 5. The effect of heat shock on hsp30 gene expression in X. laevis A6 cells.      
A) The effect of heat shock on hsp30 mRNA levels. Cells were maintained at 22 ˚C or 
subjected to a 2 h heat shock at 33 ˚C or 35 ˚C. After treatment, total RNA was isolated 
from A6 cells and quantified as described in the Materials and Methods section. Ten µg 
of total RNA was examined via northern blot hybridization analysis using an hsp30 
antisense riboprobe. Reversible blot staining was utilized to confirm equal loading and 
efficiency of transfer. The positions of 28S and 18S ribosomal RNAs are indicated with 
black arrows. These data are representative of three separate experiments. B) Effect of 
heat shock on HSP30 and actin protein levels. Cells were maintained at 22 ˚C or 
subjected to a 2 h heat shock at 33 ˚C or 35 ˚C followed by a 2 h recovery period at 22 
˚C. After treatment, cells were harvested and total protein was isolated. Twenty µg of 
protein was transferred to nitrocellulose membranes from SDS-polyacrylamide gels and 
probed with anti-HSP30 or anti-actin polyclonal antibodies. A section of a representative 
Ponceau S stained membrane that brackets a 42-kDa band (asterisk) is shown to 















Figure 6. The effect of heat shock on the localization of HSP30 in A6 cells.  
Cells were grown on base-washed glass coverslips and maintained at either 22 ˚C or 
incubated at 33 ˚C for 2 h followed by a 2 h recovery period at 22 ˚C. Actin and nuclei 
were stained directly with phalloidin conjugated to TRITC (red) and DAPI (blue), 
respectively. HSP30 was indirectly detected with an anti-HSP30 antibody and a 
secondary antibody conjugated to Alexa-488 (green). The 10 µm white scale bars are 








response to heat shock (Gellalchew and Heikkila, 2004; Manwell and Heikkila, 2007).  It 
should be noted that HSP70 was not investigated using this technique because the affinity 
purified, polyclonal anti-HSP70 antibody, that was utilized successfully in immunoblot 
analysis, was unable to specifically detect HSP70 by immunocytochemistry (Gauley et 
al., 2008).  
3.2 Effect of celastrol and MG132 on proteasome activity in Xenopus A6 cells 
Previous studies suggested that celastrol may have an inhibitory effect on 
proteasome activity in mammalian cells (Yang et al., 2006; Yang et al., 2008; He et al., 
2009). To assess the impact of celastrol on proteasome activity in Xenopus A6 cells, the 
relative levels of ubiquitinated protein and chymotrypsin-like activity were determined. 
These data were compared to the effects of the proteasome inhibitor, MG132, which was 
previously characterized in our laboratory (Young and Heikkila, 2009). The relative 
levels of ubiquitinated protein detected in heat shocked A6 cells were similar to control 
cells (Fig. 7). However, the relative accumulation of ubiquitinated protein was greater in 
cells treated with 2.5 µM celastrol for 12 or 24 h at 22 ˚C.  Furthermore, cells treated with 
2.5 µM celastrol for 24 h displayed levels of protein ubiquitination similar to cells treated 










Figure 7. The effect of celastrol and MG132 on ubiquitinated protein levels.  
A6 cells were maintained at either  22 ˚C (1), heat shocked for 2 h at 33 ˚C followed by a 
2 h recovery period at 22 ˚C (2), treated with 30 µM MG132 for 24 h (3), or incubated 
with 2.5 µM celastrol for 12 h (4) or 24 h (5), respectively. After treatment, cells were 
harvested and total protein was isolated. Sixty µg samples of protein were subjected to 
immunoblot analysis employing a mouse anti-ubiquitin monoclonal antibody. The levels 
of ubiquitinated protein in heat shocked, celastrol- or MG132-treated cells were 
compared to control A6 cells. The positions of molecular mass standards in kDa are 
shown in the first lane (M). A section of a representative Ponceau S stained membrane 
that brackets a 42-kDa band (asterisk) is shown to demonstrate equal loading and 







Past studies reported that celastrol preferentially inhibits the chymotrypsin-like 
activity of the 20S proteasome in both the purified rabbit proteasome and human prostate 
cancer cells (Yang et al., 2006; Yang et al., 2008). To determine whether celastrol has a 
similar inhibitory effect on the proteasome in A6 cells, the proteasome-glo assay was 
employed to measure chymotrypsin-like activity. Compared to control cells, 
chymotrypsin-like activity decreased by approximately 61 %, in A6 cells treated with   
2.5 µM celastrol for 12 h, and was reduced by 38 % in cells treated with celastrol for 24 h 
at 22 ˚C (Fig. 8). Celastrol-mediated proteasome inhibition was also compared to the 
effects of MG132, which acts a substrate analog of chymotrypsin-like activity in the 20S 
proteasome. An 85 % reduction in chymotrypsin-like activity occurred in cells treated 
with 30 µM MG132 for 24 h. 
3.3 Characterization of celastrol-induced HSP accumulation  
3.3.1 The effect of celastrol on HSP30 and HSP70 accumulation. 
The next phase of this study examined the effect of celastrol on HSP30 and 
HSP70 accumulation in A6 cells. While cells treated with 1 µM celastrol for 8 h 
displayed relatively low levels of detectable HSP30, maximal levels of accumulation 
occurred in cells treated with 5 µM celastrol at 22 ˚C (Fig. 9A). Maximum HSP70 
accumulation occurred in response to 5 µM celastrol for 8 h. Densitometric analysis 
revealed that in comparison to A6 cells incubated with 1 µM celastrol for 8 h, HSP30 
accumulation increased 6-fold in cells that were treated with 5 µM celastrol (Fig. 9B). 
Similarly, levels of HSP70 increased 2.5-fold in cells incubated with 2.5 µM celastrol. 









Figure 8.  Celastrol and MG132-induced inhibition of proteasomal chymotrypsin-
like activity. Cells were maintained at either 22 ˚C (Control) or treated with 30 µM 
MG132 for 24 h, 2.5 µM celastrol for 12 h, or 2.5 µM celastrol for 24 h at 22 ˚C. After 
treatment, proteasomal chymotrypsin-like activity was determined using the Promega 
Proteasome-Glo
TM 
 chymotrypsin-like cell based assay as described in Materials and 
Methods. Results are expressed as a percentage of the chymotrypsin-like activity 
observed in control cells. These data are derived from four separate experiments. The 
level of  significance of the differences between  the samples was calculated by one-way 
ANOVA with a Tukey’s post-test. Significant differences between control cells and A6 











Figure 9.  The effect of different celastrol concentrations on HSP30 and HSP70 
accumulation. A) A6 cells were maintained at either 22 ˚C (C) or treated with various 
concentrations of celastrol ranging from 1 to 7.5 µM for 8 h at 22 ˚C. After treatment, 
cells were harvested and total protein was isolated. Twenty µg of protein was subjected to 
immunoblot analysis employing anti-HSP30, anti-HSP70 or anti-actin polyclonal 
antibodies. B) Image J software was used to perform densitometric analysis of the signal 
intensity for HSP30 (grey) and HSP70 (black) protein bands of western blot images. The 
data from three separate experiments are expressed as a percentage of the maximum 
bands (2.5 and 5 µM celastrol for HSP70 and HSP30, respectively). The standard error is 
represented by vertical error bars. The level of significance of the differences between the 
samples was calculated by one-way ANOVA with a Tukey’s post-test. Significant 
differences between the maximum bands and other concentrations of celastrol are 






HSP30 accumulation compared to cells incubated with 5 µM celastrol. Similarly, the 
accumulation of HSP70 was reduced by 65 % in comparison to A6 cells exposed to      
2.5 µM celastrol. To assess the effect of prolonged exposure of celastrol on HSP 
accumulation, A6 cells were subjected to different concentrations of celastrol for 18 h at 
22 ˚C. For both HSP30 and HSP70, maximal levels of accumulation occurred in cells 
incubated with 2.5 µM celastrol (Fig. 10A). In comparison to A6 cells treated with 1 µM 
celastrol, a 50-fold increase in HSP30 occurred in response to 2.5 µM celastrol for 18 h, 
whereas HSP70 levels increased 4-fold (Fig. 10B). Similar to the results observed in 8 h 
celastrol treatments, cells incubated with 7.5 µM celastrol, displayed a 70 % and 65 % 
reduction in HSP30 and HSP70 levels, respectively compared to cells treated with        
2.5 µM celastrol.  
In time course studies, HSP30 accumulation was first detected in A6 cells treated 
with 2.5 µM celastrol for 6 h while HSP70 was detectable after 2 h. The relative levels of 
HSP30 and HSP70 increased with time reaching maximal levels in cells treated for 18 h 
(Fig. 11A). Densitometric analysis revealed that in comparison to cells treated with 
celastrol for 6 h, a 7.9-fold increase in HSP30 accumulation occurred in cells treated for 
18 h (Fig. 11B) Similarly, in comparison to cells incubated with celastrol for 2 h, HSP70 
levels increased 20-fold after 18 h. Additionally, the relative levels of HSP30 and HSP70 
accumulation were reduced by approximately 30 % to 35 % in cells exposed to celastrol 
for 24 or 48 h, in comparison to cells incubated for 18 h. To determine whether A6 cells 
were able to recover from celastrol treatment, cells were incubated with 2.5 µM celastrol 






Figure 10. The effect of prolonged exposure to various celastrol concentrations on 
HSP30 and HSP70 accumulation in A6 cells. A) Cells were maintained at 22 ˚C (C) or 
treated with different concentrations of celastrol ranging from 1 to 7.5 µM for 18 h at    
22 ˚C. After treatment, cells were harvested and total protein was isolated. Twenty µg of 
protein was subjected to immunoblot analysis employing  anti-HSP30, anti-HSP70 or 
anti-actin polyclonal antibodies. B) Image J software was used to perform densitometric 
analysis of the signal intensity for HSP30 (grey) and HSP70 (black) protein bands of 
western blot images. The data are expressed as a percentage of the maximum band      
(2.5 µM celastrol) . The standard error is represented by vertical error bars. The level of 
significance of the differences between the samples was calculated by one-way ANOVA 
with a Tukey’s post-test. Significant differences between cells exposed to 2.5 µM 
celastrol and other concentrations of celastrol (1, 5 and 7.5 µM) are indicated as               










Figure 11.  Time course of HSP30 and HSP70 accumulation in A6 cells treated with 
celastrol. A) Cells were maintained at 22 ˚C (C) or treated with 2.5 μM celastrol at 22 ˚C 
for various time periods ranging from 2 to 48 h. After treatment, cells were harvested and 
total protein was isolated. Twenty µg of protein was examined using immunoblot 
analysis employing  anti-HSP30, anti-HSP70 or anti-actin polyclonal antibodies. B) 
Image J software was used to perform densitometric analysis of the signal intensity for 
HSP30 (grey) and HSP70 (black) protein bands of western blot images. The data are 
expressed as a percentage of the mean maximum band (2.5 µM celastrol for 18 h) while, 
the standard error is represented by vertical error bars. The level of significance of the 
differences between the samples was calculated by one-way ANOVA with a Tukey’s 
post-test. Significant differences between cells exposed to 2.5 µM celastrol for 18 h and 
other time points (2 to 48 h) are indicated as * (p < 0.05). These data are representative of 







The levels of HSP30 in A6 cells recovering from celastrol treatment remained 
consistently high from 4  to 24 h of recovery, with reduced levels of HSP30 occurring in 
cells allowed to recover for 48 h (Fig. 12). HSP70 accumulation patterns were 
consistently high from 4 to 12 h of recovery and decreased after 18 h, with relatively low 
HSP70 levels occurring in cells allowed to recover for 48 h. Cells were also examined 
using phase contrast microscopy to detect morphological changes in cells treated with   
2.5 µM celastrol for 18 h. Control cells displayed a slightly elongated and dome-like 
morphology and formed a confluent monolayer on the surface of tissue culture flasks 
(Fig.13). Upon treatment with celastrol for 18 h, most cells appeared round and were less 
confluent. Remaining A6 cells were allowed to recover in fresh L-15 media for 24 h, 48 h 
and 4 d at 22 ˚C. After 4 days of recovery, a portion of  remaining cells were confluent 
and displayed typical epithelial morphology. 
3.3.2 Analysis of the regulation of celastrol-induced hsp30 and hsp70 gene 
expression  
Previous studies with X. laevis have shown that the induction of hsp genes by 
various stressors including heat shock and proteasomal inhibition are regulated, at least in 
part, at the level of transcription (Heikkila, 2003; Heikkila, 2004; Young and Heikkila, 
2009). This phenomena involves HSF1-mediated synthesis of hsp mRNA. In the present 
study, northern blot hybridization analysis determined that celastrol treatment induced the 
accumulation of both hsp30 and hsp70 mRNA. For example, hsp30 and hsp70 mRNA 
accumulation was observed in cells exposed to 2.5 µM celastrol for 6, 8 and 12 h time 







Figure 12.  HSP30 and HSP70 protein levels in A6 cells recovering from celastrol 
treatment. Cells were maintained at 22 ˚C (C) or treated with 2.5 µM celastrol for 18 h 
followed by varying recovery periods in fresh L-15 media ranging from 4 to 48 h at        
22 ˚C. After treatment, cells were harvested and total protein was isolated. Twenty µg of 
protein was examined using immunoblot analysis employing  anti-HSP30, anti-HSP70 or 













Figure 13.  Examination of the morphology of A6 cells recovering from celastrol 
treatment. A6 cells were cultured in FBS-supplemented L-15 media at 22C in T-75cm
2 
tissue culture flasks.  Cells were then exposed to 2.5 µM celastrol for 18 h followed by a 
24 h, 48 h, or 4 day recovery (Rec.) period in fresh L-15 media at 22 ˚C. Phase contrast 
microscopy was employed to examine the morphological changes occurring in cells 
recovering from celastrol treatment. Subsequently, A6 cells were photographed using a 
Nikon coolpix 995 digital camera (400X final magnification) and compared to control 







times, with the highest level of accumulation occurring in cells treated with celastrol for 
12 h (Fig. 14). Additionally, in comparison to A6 cells treated with celastrol for 6 h, 
enhanced levels of hsp70 mRNA accumulation were observed after 8 and 12 h incubation 
periods. 
Additionally, past experiments in our laboratory employed the inhibitor, 
KNK437, to show that stress-induced hsp gene expression in X. laevis A6 cells was 
controlled at the level of HSF1 DNA binding (Manwell and Heikkila, 2007; Voyer and 
Heikkila, 2008). In the current study, relative levels of HSP30 and HSP70 in A6 cells 
treated with 2.5 µM celastrol alone, were compared to cells incubated with celastrol for 8, 
12 or 18 h following a 6 h pre-treatment with 100 µM KNK437 (Fig. 15A). 
Densitometric analysis demonstrated that pre-treatment with KNK437, suppressed 
celastrol-induced HSP30 accumulation by 91 %, 86 %, and 73 % for cells treated with 
celastrol for 8, 12 and 18 h, respectively. Similarly, following pre-treatment with 
KNK437, a decrease in HSP70 by 88 %, 72 %, and 65 % occurred in cells incubated with 
celastrol for 8, 12 and 18 h, respectively (Fig. 15B).  
3.4 The effect of mild heat shock on celastrol-induced HSP30 and HSP70 
accumulation in A6 cells 
The next sets of experiments were designed to investigate the effect of elevated 
temperatures on celastrol-induced hsp gene expression, in X. laevis A6 cells. In cells 
exposed to either mild heat shock (30 ˚C) or celastrol (2.5 µM) alone for 4 h, relatively 
low levels of HSP30 and HSP70 accumulation were detected (Fig. 16A). However, an 









Figure 14. Time course of hsp30 and hsp70 mRNA accumulation in A6 cells treated 
with celastrol. A6 cells were maintained at 22 ˚C (C) or incubated with 2.5 µM celastrol 
for 6, 8, or 12 h. After treatment, total RNA was isolated from A6 cells and quantified as 
described in the Materials and Methods section. Ten µg of total RNA was analyzed via 
northern hybridization analysis using hsp30  and hsp70 antisense riboprobes. Reversible 
blot staining was utilized to confirm equal loading and efficiency of transfer. The 
positions of  28S and 18S ribosomal RNAs are indicated with black arrows. These data 











Figure 15.  The effect of KNK437 on celastrol-induced HSP30 and HSP70  
accumulation.  A) Cells were treated with 2.5 µM celastrol for 8, 12, or 18 h with or 
without a 6 h pre-treatment with 100 µM KNK437 at 22 ˚C. After treatment, cells were 
harvested and total protein was isolated. Twenty µg of protein was subjected to 
immunoblot analysis employing  anti-HSP30, anti-HSP70 or anti-actin polyclonal 
antibodies. B) Image J software was used to perform densitometric analysis of the signal 
intensity for HSP30 (grey) and HSP70 (black) protein bands of western blot images. The 
ability of KNK437 to inhibit celastrol-induced HSP30 and HSP70 accumulation at each 
time point was graphed as average percent inhibition. The standard error is represented 
by vertical error bars. Two-tailed, paired T-tests were performed to analyze the 
differences between samples. Significant differences between cells exposed to celastrol 
with or without a 6 h KNK437 pre-treatment are indicated as * (p < 0.05). These data are 











Figure 16.  The effect of mild heat shock on 2.5 µM celastrol-induced HSP30 and 
HSP70 accumulation. A) Cells were maintained at 30 ˚C, treated with 2.5 µM celastrol 
at 22 ˚C, or treated with 2.5 µM celastrol at 30 ˚C for 4 or 8 h. After treatment, cells were 
harvested and total protein was isolated. Twenty µg of protein was subjected to 
immunoblot analysis employing  anti-HSP30, anti-HSP70 or anti-actin polyclonal 
antibodies. B) Image J software was used to perform densitometric analysis of the signal 
intensity for HSP30 (grey) and HSP70 (black) protein bands of western blot images. Data 
are expressed as a percentage of the maximum band (combined celastrol and mild heat 
shock treatment) at each time point. The standard error  is represented by vertical error 
bars. The level of significance of the differences between the samples was calculated by 
one-way ANOVA with a Tukey’s post-test. Significant differences between the 
maximum signal at each time point and other treatments (celastrol or mild heat shock 








stressors concurrently for 4 h. Densitometric analysis revealed that after 4 h of combined 
treatment, HSP30 and HSP70 levels were increased to values greater than the sum of the 
HSP levels induced by each stressor individually (Fig. 16B). Similarly, in cells treated 
with celastrol for 8 h, the relative accumulation of HSP30 in A6 cells treated with 
celastrol at 30 ˚C, was greater than the levels detected in response to each stress alone. 
Although they were slightly enhanced, the levels of HSP70 resulting from simultaneous 
exposure to both stresses for 8 h, were not greater than the sum of accumulation induced 
in A6 cells treated individually with either celastrol or mild heat shock. 
3.5 The effect of combined exposure to celastrol and MG132 on HSP accumulation 
To examine the effect of two different proteasome inhibitors on HSP30 and HSP70 
accumulation in A6 cells, immunoblot analysis was carried out on cells exposed to low 
concentrations of both celastrol and MG132. While relatively low levels of HSP30 
occurred in cells treated with celastrol (1 µM) or MG132 (5 µM) for 8 or 16 h 
individually, HSP30 levels were enhanced in cells treated with both stressors 
simultaneously for 8 or 16 h (Fig. 17A). Densitometric analysis revealed that the 
increased levels of HSP30 observed in cells treated with both stressors (1 µM celastrol 
and 5 µM MG132) concurrently, were greater than the sum of HSP30 caused by each 
stressor individually (Fig. 17B). To assess the impact of higher concentrations of MG132 
on celastrol-induced HSP accumulation, A6 cells incubated with both 1 µM celastrol and 
10 µM MG132 were examined. The combined stresses resulted in an increase in HSP30 








Figure 17. The effect of concurrent 1 µM celastrol and 5 µM MG132 exposure on 
HSP30 and HSP70 accumulation. A) A6 cells were incubated with 1 µM celastrol,       
5 µM MG132, or both simultaneously for 8 or 16 h at 22 ˚C. After treatment, cells were 
harvested and total protein was isolated. Twenty µg of protein was subjected to 
immunoblot analysis employing  anti-HSP30, anti-HSP70 or anti-actin polyclonal 
antibodies. B) Image J software was used to perform  densitometric analysis of the signal 
intensity for HSP30 (grey) and HSP70 (black) protein bands of western blot images. Data 
are expressed as a percentage of the maximum band  (combined 1 µM celastrol and 5 µM 
MG132 treatment) at each time point. The standard error  is represented by vertical error 
bars. The level of significance of the differences between the samples was calculated by 
one-way ANOVA with a Tukey’s post-test. Significant differences between the 
maximum signal at each time point and other treatments (celastrol or 5 µM MG132 








stressor (Fig. 18). In contrast to the synergistic effect that both stressors had on 
HSP30 levels in A6 cells, the patterns of HSP70 accumulation observed in cells treated 
with both celastrol and MG132 simultaneously for 8 or 16 h, were not significantly 
different from the HSP70 levels induced by MG132 (5 or 10 µM) treatment alone.   
3.6  A comparison of celastrol-induced morphological changes in A6 cells grown in 
tissue-culture flasks or on glass coverslips. 
A comparison of the morphology of celastrol-treated A6 cells grown in tissue 
culture flasks or on glass coverslips was carried out prior to immunocytochemistry and 
LSCM experiments. Cells were cultured in tissue culture flasks or on base-washed glass 
coverslips followed by treatment with 1, 2.5, or 5 µM celastrol for 4 or 8 h at 22 ˚C (Figs. 
19 and 20). While cells incubated with 1 µM celastrol for 4 h appeared control-like with 
slightly reduced confluency, a small proportion of cells displayed a round morphology 
and were sparsely distributed after 8 h. Cells treated with 2.5 or  5 µM celastrol were 
sparsely distributed on the surface of both tissue culture flasks and coverslips after 4 and 
8 h of treatment. The proportion of cells appearing round increased over time in response 
to 2.5 µM celastrol with the majority of cells displaying a circular morphology after 8 h. 
However, the majority of cells exposed to 5 µM celastrol became round after 4 h with no 
additional changes in appearance in response to 8 h treatments. Overall, A6 cells had less 
adherence to the surface of glass coverslips than they did to the surface of tissue culture 
flasks. Growing A6 cells on poly L-lysine coated or acid-washed coverslips in an attempt 








Figure 18. The effect of concurrent 1 µM celastrol and 10 µM MG132  exposure on 
HSP30 and HSP70 accumulation. A) Cells were subjected to 1 µM celastrol, 10 µM 
MG132, or both simultaneously at 22 ˚C for 8 or 16 h time periods. After treatment, cells 
were harvested and total protein was isolated. Twenty µg of protein was subjected to 
immunoblot analysis employing  anti-HSP30, anti-HSP70, and anti-actin polyclonal 
antibodies. B) Image J software was used to perform  densitometric analysis of the signal 
intensity for HSP30 (grey) and HSP70 (black) protein bands of western blot images. Data 
are expressed as a percentage of the maximum band  (combined 1 µM celastrol and 10 
µM MG132 treatment) at each time point. The standard error  is represented by vertical 
error bars. The level of significance of the differences between the samples was 
calculated by one-way ANOVA with a Tukey’s post-test. Significant differences between 
the maximum signal at each time point and other treatments (celastrol or 5 µM MG132 













Figure 19. Examination of the morphology of A6 cells treated with different 
concentrations of celastrol for 4 h. Cells were grown in
 
tissue culture flasks or on base-
washed glass coverslips at 22 ˚C in L-15 media containing FBS. A6 cells were then 
treated with 1, 2.5, or 5 µM celastrol for 4 h at 22 ˚C. Phase contrast microscopy was 
employed to examine the morphology of A6 cells exposed to celastrol for 4 h. Cells were 
then photographed using a Nikon coolpix 995 digital camera (400X final magnification) 











Figure 20. Examination of the morphology of A6 cells treated with different 
concentrations of celastrol for 8 h. A6 cells were cultured in tissue culture flasks or on 
base-washed glass coverslips at 22 ˚C in L-15 media containing FBS. Cells were then 
treated with 1, 2.5, or 5 µM celastrol for 8 h at 22 ˚C. Phase contrast microscopy was 
employed to examine A6 cell morphology following celastrol treatment. Cells were 
photographed using a Nikon coolpix 995 digital camera (400X final magnification) and 







cells exposed to 2.5 or 5 µM celastrol for longer than 8 h (e.g. 12, 18 or 24 h) did not 
adhere to the coverslips after the fixation and protocol required for immunocytochemical 
analysis. Thus, subsequent experiments employed treatments of 1 or 2.5 µM celastrol for 
4 or 8 h at 22 ˚C. 
3.7 The localization of HSP30 in A6 cells treated with celastrol and MG132 
As shown in Figure 21, preliminary experiments documented MG132-induced 
HSP30 localization in A6 cells. Cells incubated with 30 µM MG132 for 8 and 24 h, 
displayed levels of HSP30 accumulation primarily in the cytoplasm with some staining in 
the nucleus and no detectable levels in the nucleolus. While approximately 80 % of cells 
treated with MG132 for 8 h displayed detectable HSP30 accumulation, this value 
increased to 100  % in cells treated for 24 h.  Relatively large circular HSP30 staining 
structures were observed in cells treated with MG132 for 8 h. In cells incubated for 8 h 
with MG132, a slight disorganization in actin cytoskeleton structure was observed. As 
shown in Figures 22 and 23, incubation with celastrol (1 µM and 2.5 µM) also resulted in 
the accumulation of HSP30 in the cytoplasm and nucleus but not in the nucleolus. In 
response to 1 µM celastrol, approximately 30 % and 35 % of A6 cells displayed HSP30 
accumulation after 4 and 8 h, respectively. While HSP30 accumulation was detected in 
45 % of cells treated with 2.5 µM celastrol for 4 h, the proportion of cells with HSP30 
increased to 80 % after 8 h. Similar to the results found in cells treated with MG132, 
relatively large foci of HSP30 were detected within the cytoplasm of some cells treated 









Figure 21. The effect of MG132 on the localization of HSP30 in A6 cells. Cells were 
grown on base-washed glass coverslips and either maintained at 22 ˚C or exposed to      
30 µM MG132 for 8 or 24 h at 22 ˚C. Actin and nuclei were stained directly with 
phalloidin conjugated to TRITC (red) and DAPI (blue), respectively. HSP30 was 
indirectly detected with an anti-HSP30 antibody and a secondary antibody conjugated to 
Alexa-488 (green). The white arrows indicate large circular cytoplasmic foci of HSP30 
observed in some cells treated with 30 µM MG132 for 8 h. The 10 µm white scale bars 
are indicated at the bottom right section of each panel. These data are representative of 
three separate experiments. It should be noted that colocalization of HSP30 with actin 
was not observed during confocal microscopy. However, the apparent colocalization in 













Figure 22. The effect of 1 µM celastrol on the localization of HSP30 in A6 cells. Cells 
were cultured on base-washed glass coverslips and maintained at either  22 ˚C or 
incubated with 1 µM celastrol for 4 or 8 h at 22 ˚C. Actin and nuclei were stained directly 
with phalloidin conjugated to TRITC (red) and DAPI (blue), respectively. HSP30 was 
indirectly detected with an anti-HSP30 antibody and a secondary antibody conjugated to 
Alexa-488 (green). Large circular foci of HSP30 present in some cells treated with 1 µM 
celastrol for 8 h, are indicated by the white arrows. The 10 µm white scale bars are 















Figure 23. The effect of 2.5 µM celastrol on the localization of HSP30. Cells were 
grown on base-washed glass coverslips and maintained at either  22 ˚C or treated with  
2.5 µM celastrol for 4 or 8 h at 22 ˚C. Actin and nuclei were stained directly with 
phalloidin conjugated to TRITC (red) and DAPI (blue), respectively. HSP30 was 
indirectly detected with an anti-HSP30 antibody and a secondary antibody conjugated to 
Alexa-488 (green). The white arrows indicate large circular cytoplasmic foci of HSP30 
observed in some cells treated with 2.5 µM celastrol for 4 h. The 10 µm white scale bars 
are indicated at the bottom right section of each panel. These data are representative of 
five separate experiments. It should be noted that colocalization of HSP30 with actin was 
not observed during confocal microscopy. However, the apparent colocalization in Figure 








control cells, treatment with celastrol produced changes to the general morphology and F-
actin organization in A6 cells. For example, cells incubated with celastrol were rounder in 
shape and displayed some disorganization in the cytoskeleton with a loss of control-like 
stress fibers and staining of actin primarily at the periphery of some cells.  
4 Discussion 
The present study has shown that celastrol inhibited proteasomal activity and 
induced hsp30 and hsp70 gene expression in Xenopus laevis A6 kidney epithelial cells. 
Initial studies demonstrated that exposure of A6 cells to celastrol enhanced the relative 
levels of ubiquitinated protein. These results were comparable to MG132-induced 
ubiquitinated protein accumulation presented in this study and previously in our 
laboratory (Young and Heikkila, 2009). Additionally, Xenopus A6 cells treated with 2.5 
µM celastrol exhibited a 58 % to 78 % decrease in chymotrypsin-like activity. Taken 
together the celastrol-induced increase in the accumulation of ubiquitinated proteins and 
decreased chymotrypsin-like activity in A6 cells, is an indicator of proteasomal inhibition 
as reported previously in other systems (Yang et al., 2006; Dai et al., 2009). In 
comparison to A6 cells, similar results were obtained in mammalian cells, since celastrol 
increased protein ubiquitination in a dose-dependent manner and inhibited chymotrypsin-
like activity by 55 % in human prostate cancer cells (PC-3 and LNCaP) (Yang et al., 
2006). In Xenopus laevis A6 cells, like other eukaryotic systems, the ubiquitin-
proteasome system (UPS) is the primary degradation pathway for misfolded or damaged 
proteins (Lee and Goldberg, 1998b; Malik et al., 2001). Previous studies have 
demonstrated that proteasome inhibition results in the accumulation of ubiquitinated 
cellular proteins targeted for degradation within the cytosol (Bush et al., 1997; Lee and 
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Goldberg, 1998b; Malik et al., 2001; Liao et al., 2006). Since misfolded proteins possess 
exposed hydrophobic amino acid residues, increased concentrations of these non-native 
proteins by means of proteasomal inhibition can result in aggregate formation, which is 
detrimental to cell function (Hartl, 1996; Lee and Goldberg, 1998b; Hartl and Hayer-
Hartl, 2009).  
As mentioned above, treatment of  X. laevis A6 cells with celastrol resulted in the 
accumulation of hsp30 and hsp70 mRNA as well as HSP30 and HSP70 protein. In these 
experiments, celastrol had no detectable effect on actin levels. These findings are in 
agreement with previous studies in our laboratory, which demonstrated that  proteasome 
inhibition by MG132 induced hsp gene expression in A6 cells (Young and Heikkila, 
2009). Previously, the effects of celastrol on hsp gene expression were also examined in 
yeast, mouse and human systems (Westerheide et al., 2004; Cleren et al., 2005; Chow and 
Brown, 2007; Zhang and Sarge, 2007; Trott et al., 2008; Kalmar and Greensmith, 2009). 
For example, in HeLa cells, Westerheide et al. (2004) demonstrated that celastrol 
activated an hsp70.1 promoter-luciferase reporter gene and induced HSP70 accumulation 
to levels that were comparable to heat shock. Also, in human neuronal cell lines, celastrol 
induced increased levels of HSP27, HSP32, HSP70 and HSP70B (Chow and Brown, 
2007), while in vivo celastrol injections induced increased levels of HSP70 in the striatum 
of rat models of Huntington’s disease and the substantia nigra of mouse models of 
Parkinson’s disease (Cleren et al., 2005).   
In Xenopus, the stress-induced expression of hsp genes is mediated by HSF1 
DNA-binding activity (Heikkila, 2003; Voellmy, 2004). Although, the mechanism by 
which HSF1 is activated is unknown, it is thought that this process is triggered by the 
93 
 
accumulation of misfolded or damaged proteins in the cytosol (Morimoto and Santoro, 
1998; Voellmy, 2004; Morimoto, 2008). The current study determined that pretreatment 
of A6 cells with the HSF1 inhibitor, KNK437, prior to the application of celastrol 
repressed the accumulation of both HSP30 and HSP70. This suggested that celastrol-
induced hsp gene expression in Xenopus A6 cells was likely controlled, at least in part, at 
the level of transcription through the activation of HSF1 DNA-binding. These results are 
in agreement with previous studies in Xenopus, demonstrating that pretreatment with 
KNK437, inhibited heat shock, chemical stress, and MG132-induced hsp gene expression 
(Manwell and Heikkila, 2007; Voyer and Heikkila, 2008; Young and Heikkila, 2009). 
Additionally, previous studies have investigated the effect of celastrol on HSF1 activity 
in yeast and mammalian cells (Westerheide et al., 2004; Trott et al., 2008). In yeast, Trott 
et al. (2008) determined that celastrol activated an hsp70 promoter-LacZ reporter gene, 
by inducing HSF1 DNA-binding activity. Furthermore, in HeLa cells expressing an 
hsp70.1 promoter reporter construct, studies using gel shift analysis demonstrated that 
celastrol caused hyperphosphorylation of HSF1. Subsequent chromatin 
immunoprecipitation in vivo experiments verified that celastrol induced HSF1 DNA-
binding activity to the endogenonous hsp70.1 promoter (Westerheide et al., 2004).  
In time course experiments with A6 cells exposed to 2.5 µM celastrol, levels of 
HSP70 and HSP30 were first detectable in cells after 2 and 6 h, respectively. While 
maximal levels were noted after 18 h. In contrast, continuous exposure of A6 cells to heat 
shock induced detectable levels of HSP30 and HSP70 after 1 h and maximal levels of 
HSP accumulation were observed after 2 h (Darasch et al., 1988). Reasons for the 
different temporal patterns of HSP accumulation in A6 cells subjected to heat shock and 
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celastrol are unknown. It is possible that the delay in maximal HSP accumulation in A6 
cells treated with celastrol may be due to the time required for celastrol entry into the cell 
and the time required to increase the non-native protein levels that will activate HSF1 
DNA-binding activity. In support of this possibility a delayed accumulation of HSPs 
compared to heat shock was observed in A6 cells subjected to sodium arsenite, cadmium 
chloride, MG132, or herbymicin A (Darasch et al., 1988; Ohan et al., 1998; Gauley and 
Heikkila, 2006; Woolfson and Heikkila, 2009; Young and Heikkila, 2009) For example, 
MG132-treated A6 cells displayed levels of HSP70 and HSP30 after 4 and 8 h, 
respectively with maximal HSP accumulation occurring after 24 h (Young and Heikkila, 
2009).  Also, in A6 cells exposed to cadmium chloride, HSP30 and HSP70 were 
detectable after 5 and 8 h, respectively, with maximal levels of HSPs occurring after 16 h 
(Woolfson and Heikkila, 2009). 
 The present study also investigated the pattern of HSP accumulation in Xenopus 
A6 cells recovering from celastrol treatment. Relative levels of HSP30 and HSP70 
accumulation remained elevated for 18-24 h after the removal of celastrol. These findings 
were similar to results described in A6 cells recovering from MG132, in which the 
relative levels of HSP30 and HSP70 remained elevated for up to 24 h (Young and 
Heikkila, 2009). Additionally, a prolonged accumulation of HSPs was reported in 
Chinese hamster ovary cells recovering from proteasomal inhibition (Kovacs et al., 
2006). The prolonged accumulation of HSPs in A6 cells recovering from celastrol may be 
due to continued  hsp gene transcription or an increase in hsp mRNA or HSP stability, as 
suggested previously for sodium arsenite (Darasch et al., 1988). Nevertheless, it is likely 
that elevated levels of HSPs are beneficial to celastrol-treated cells since relatively high 
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concentrations of ubiquitinated cellular proteins that accumulate within the cytosol may 
require an extended amount of time to re-establish protein homeostasis by degradation 
(Bush et al., 1997; Lee and Goldberg, 1998b; Liao et al., 2006).  
In X. laevis A6 cells, concurrent treatment with both mild heat shock and 
celastrol, induced elevated levels of HSP30 and HSP70 accumulation. In fact, the relative 
levels of HSP30 displayed in cells treated with both stressors were greater than the sum 
of the values found with each stressor individually. In comparison to individual 
treatments, an increased amount of HSP70 accumulation was observed in A6 cells treated 
concurrently with both stressors for 4 h.  However, the relative levels of HSP70 
accumulation displayed in cells exposed to both celastrol and mild heat shock for 8 h 
were not substantially different from those resulting from celastrol alone. Similarly, 
increased levels of HSP30 and HSP70 accumulation were observed in Xenopus A6 cells 
treated concurrently with 30 µM MG132 and mild heat shock temperatures ranging from 
24-30 ˚C (Young and Heikkila, 2009). Additionally, our laboratory reported an increase 
in hsp gene expression in A6 cells when a mild heat shock was combined with low 
concentrations of cadmium chloride, sodium arsenite, herbimycin A or hydrogen 
peroxide (Heikkila et al., 1987; Briant et al., 1997; Muller et al., 2004; Woolfson and 
Heikkila, 2009). The mechanism responsible for increased levels of HSP30 and HSP70 in 
A6 cells concurrently exposed to celastrol and mild heat shock is unknown. As 
mentioned previously, celastrol can induce an increase in the relative levels of 
ubiquitinated protein destined for degradation by inhibiting the proteasome. Additionally, 
heat shock can induce a generalized unfolding of intracellular proteins. Thus, it is 
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possible in A6 cells, that a mild heat shock  and celastrol treatment in combination will 
elevate the total level of non-native protein to a threshold level required for HSF1 
activation. Evidence supporting the existence of a threshold level for HSF1 activation has 
been described in a number of systems including mouse T-lymphocytes and testis, 
intertidal mussels, HeLa cells and Xenopus (Sarge, 1995; Lee et al., 1995; Ali et al., 
1997; Buckley et al., 2001; Gothard et al., 2003). 
The current study also investigated the combined effects of the proteasome 
inhibitors, celastrol and MG132 on hsp gene expression in Xenopus A6 cells. Similar to 
results observed with mild heat shock and celastrol, treatment with low concentrations of 
celastrol (1 µM) and MG132 (5 µM or 10 µM) resulted in enhanced levels of HSP30 to 
values higher than the sum of those produced by each stressor individually. Also, levels 
of HSP70 accumulation were increased in A6 cells exposed to both celastrol and MG132 
simultaneously, but were not substantially higher than those observed in cells exposed to 
MG132 alone. Therefore, the combined stresses of celastrol plus MG132 have a different 
effect on the pattern of HSP30 and HSP70 accumulation in A6 cells. Previously, our 
laboratory reported different accumulation patterns of  HSP30, HSP70, and HSP110 in 
Xenopus cultured cells treated with sodium arsenite (Gauley et al., 2008). For example, 
while enhanced levels of HSP70 and HSP110 were observed in A6 cells treated with 10 
µM sodium arsenite, increased HSP30 accumulation was first detected in cells incubated 
with 25 µM concentrations (Gauley et al., 2008). Although, the mechanism responsible 
for the different levels of HSP30 and HSP70 in A6 cells exposed to combined celastrol 
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treatment is not known, this phenomenon may reflect specific physiological roles for each 
HSP during proteasome inhibition.  
The effect of celastrol on A6 cell morphology was also examined using phase-
contrast microscopy. Treatment with celastrol modified A6 cell structure in a dose- and 
time-dependent manner. Control cells displayed an elongated morphology and formed a 
confluent monolayer adherent to the surface of tissue culture flasks and coverslips. In 
contrast, A6 cells exposed to celastrol exhibited reduced adherence, cytoplasmic 
retraction, and a rounder cell shape. The effects of celastrol on cellular morphology have 
been described previously in mammalian cells (Yang et al., 2006; Chow and Brown, 
2007). For example, cell shrinkage and rounder cell bodies were observed in human and 
rodent neuronal cells treated with celastrol (Chow and Brown, 2007). The morphological 
properties of A6 cells recovering from celastrol were also examined during this study. 
Compared to the round appearance of cells incubated with celastrol for 18 h, after 4 days 
of recovery A6 cells were confluent and displayed control-like morphology. The 
molecular pathway responsible for celastrol-induced morphological changes in A6 cells 
is unknown. However, reduced NF-kβ activity has been linked to decreased levels of 
various cell adhesion molecules (CAMs) required for proper attachment of the 
cytoskeleton to the extra cellular matrix (ECM) including E-selectin, ICAM-I and 
VCAM-I (Collins et al., 1995; Tozawa et al., 1995; Collins and Cybulsky, 2001). 
Furthermore, celastrol- mediated inhibition of NF-kβ, has been reported in mammalian 
cancer cell lines (Lee et al., 2006; Kim et al., 2009; He et al., 2009). Thus, suppression of 
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NF-kβ activity caused by decreased proteasome function may play a role in the round 
morphology and reduced adherence of A6 cells exposed to celastrol. 
Immunocytochemistry and LSCM were employed to examine the localization of 
HSP30 in X. laevis A6 cells treated with celastrol or MG132. Cells exposed to these 
stressors displayed HSP30 accumulation primarily in the cytoplasm in a punctate pattern 
with some staining in the nucleus. The punctate pattern of HSP30 accumulation may 
represent the stress-induced formation of HSP30 multimeric structures that are required 
for sHSP function (Ohan et al., 1998; MacRae, 2000; Van Montfort et al., 2001). 
Additionally, relatively large HSP30 staining foci were detected in some X. laevis A6 
cells incubated with celastrol or MG132.  Similar structures were reported in A6 cells 
exposed to cadmium chloride, sodium arsenite or MG132 (Voyer and Heikkila, 2008; 
Woolfson and Heikkila, 2009; Young and Heikkila, 2009). Although the identity of these 
large structures is unknown, it has been suggested that they are inclusion bodies 
containing HSP30 bound to unfolded proteins and may be associated with the molecular 
chaperone function of HSP30 (Fernando and Heikkila, 2000; Heikkila, 2003; Heikkila, 
2004; Young and Heikkila, 2009). In support of this concept, previous studies have 
determined that proteasome inhibition significantly increased the formation of cytosolic 
aggresomes that are composed of smaller protein aggregates also known as inclusion 
bodies (Garcia-Mata, 1999). Results previously described with MG132, determined that 
these foci occurred in response to high concentrations of MG132 (Young and Heikkila, 
2009). In contrast, A6 cells treated with relatively low concentrations of celastrol for 8 h 
also displayed HSP30 staining foci. Lastly, the current study determined that treatment of 
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A6 cells with celastrol disrupted the actin cytoskeleton with most cells displaying a 
rounder morphology compared to control cells. It was also noted that treatment with 
higher concentrations of celastrol caused a collapse in the cytoskeleton with actin staining 
primarily in the periphery of A6 cells. As mentioned previously, this may be related to 
celastrol-mediated inhibition of the NF-kβ signalling pathway (Collin et al., 1995; 
Tozawa et al., 1995; Collins and Cybulsky, 2001). 
In summary, the present study has shown for the first time in an amphibian 
system, that the proteasome inhibitor, celastrol, induced hsp30 and hsp70 gene 
expression, increased the accumulation of ubiquitinated proteins, inhibited chymotrypsin-
like activity and disrupted the actin cytoskeleton. Understanding the effect that celastrol 
has on Xenopus hsp gene expression is of importance given the potential therapeutic role 
for HSPs in various human diseases. This study leaves some unanswered questions about 
the effects of celastrol on hsp gene expression. Therefore, further analysis on the 
relationship between celastrol-induced proteasome inhibition and the accumulation of 
HSPs is required. Future studies should examine the effect of celastrol on other Xenopus 
hsp genes such as BiP, hsp47 and hsp90. Mammalian studies have suggested that 
proteasome inhibition may have an impact on molecular chaperones in the endoplasmic 
reticulum and HSP90 (Bush et al., 1997; Banerji, 2009) Also, the effect of proteasome 
inhibition on hsp gene expression during animal development has not been investigated. 
Given the advantages of the Xenopus embryonic system including microinjections and 
transgenic methodology, future experiments should examine the effects of  celastrol on 
hsp gene expression during early development. Future research should also investigate 
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whether celastrol-induced HSP accumulation can have a cytoprotective effect in A6 cells 
subjected to a thermal challenge. Recently, the acquisition of thermotolerance was 
reported following proteasomal inhibition by celastrol in mammals and by MG132 in A6 
cells (Westerheide et al., 2004;Young and Heikkila, 2009). Previous studies have also 
shown that celastrol can induce apoptosis through inhibition of the NF-kβ signalling 
pathway (Lee et al., 2006; Idris et al., 2009; He et al., 2009). Therefore, the potential 
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